• What's Ur Story (Mental Health) brings men of all ages together - Men are three times more likely to commit suicide than women, according to statistics from The Samaritans. * This is why a new series of events organised by London-based social enterprise, The MABA Group, aims to bring younger and older men together to support each other and discuss their challenges. This groundbreaking initiative aims to help foster connections between young men and older men who share common interests, struggles and experiences. The first event, being held on 15th June, the day before Father’s Day, aims to use the power of football to bring men together and have a chance to talk about their issues. As well as a friendly football match, there also will be various talks put on for the day, facilitated by the experts at the MABA Group, which specialises in helping young people through sport, education and music. This event, to be held at the Phoenix Centre, Croydon, will provide a platform to allow individuals to meet, connect and relate to one another, with the goal of providing support, guidance and advice to help navigate life’s challenges – all whilst experiencing a shared joy in football. Jean-Terach Bavangila, mentor and CEO of the MABA Group social enterprise explains: “The main objective of our What’s Ur Story (Mental Health) event is to challenge the stigmas around men’s mental health. Men just don’t share about their problems which can lead to mental health issues and sadly suicide in some cases. We want to show men there is a way to thrive.” “This series of events also aims to bridge the gap between different generations and groups, emphasising the importance of intergenerational dialogue and understanding. By bringing together individuals from diverse age groups, backgrounds, and experiences, the initiative seeks to demonstrate that no one is alone in their struggles and challenges,” he adds. The day will provide a safe and supportive environment for men to share their stories, experiences, and concerns, knowing that they will be met with empathy, understanding, and encouragement from their counterparts. This sense of camaraderie and solidarity fosters a sense of belonging and community among attendees, empowering them to navigate life's challenges with resilience and confidence. The event is a transformative initiative that benefits both young and older men alike. By fostering intergenerational connections, promoting empathy and understanding, and providing a platform for shared learning and support, it aims to empower men of all ages to build meaningful relationships, overcome challenges, and thrive in all aspects of their lives. The first What’s Ur Story (Mental Health) event will be held on Saturday 15th June at the Phoenix Centre. Spaces for the first event are extremely limited due to phenomenal demand but men are warmly invited to put their names down for future events by contacting The MABA Group at: info@themabagroup.com -ENDS- *Samaritans Suicide Factsheet: https://www.samaritans.org/about-samaritans/research-policy/suicide-facts-and-figures/latest-suicide-data/ NOTES TO EDITORS: About The MABA Group The MABA Group CIC is a mobile Social Enterprise organisation dedicated to empowering the betterment of all people in general but with a particular focus on young people. The organisation focuses on teaching life skills through sports, music, creative arts and education, both privately and through working with local government organisations. As well as working with people with special needs and rehabilitating ex young offenders, the organisation also provides a career mentoring service, CV-building service and expert health and wellness advice for those in need. Website: https://themabagroup.com About Jean-Terach Bavangila Jean-Terach Bavangila, known to most as JT, CEO of the MABA Group social enterprise, is an ex-professional footballer, mentor, coach and public speaker. He came to the UK as a war refugee from the Republic of Congo (Congo Brazzaville) and grew up in one of the most deprived areas of east Hackney, suffering homelessness, bullying and extreme poverty. However, two things saved him from sinking into a life of hopelessness and deprivation – football and his father’s inclination to take in fellow refugees, many of whom became mentors to him. Now that he has retired from professional football, JT has a mission to mentor and empower young people, particularly from deprived backgrounds to live the lives they deserve and follow their dreams. JT is a popular public speaker and is available to speak at any event on a range of topics. He can be contacted on: 07474571002 or via LinkedIn at: https://www.linkedin.com/in/jean-terach-bavangila  ^update (Added: Fri May 03 2024 Hits: 57 Rating: 0.00 Votes: 0) Rate It

• Rapid Diagnostics Market Forecasted to Exceed $26.4 Billion by 2029, - Meticulous Research®, a globally recognized leader in market research, has recently released a comprehensive report titled "Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecasts to 2029". This detailed analysis offers invaluable insights into the rapid diagnostics market landscape, forecasting significant growth potential and emerging trends. Download Free Research Report PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5240?utm_source=pressrelease&utm_medium=social&utm_campaign=product&utm_content=03-05-2024 Market Projection The report forecasts a robust growth trajectory for the global rapid diagnostics market, with a projected value of $26.40 billion by 2029. This growth is anticipated to occur at a Compound Annual Growth Rate (CAGR) of 1.4% from 2022 to 2029. Factors driving this expansion include the escalating demand for Point-of-Care (POC) diagnostics, the increasing prevalence of chronic diseases coupled with the aging population, the imperative need for rapid decision-making in emergency healthcare settings, and the advent of technological innovations. However, challenges such as variances in test results may pose constraints to market growth. Market Segmentation and Analysis The global rapid diagnostics market is segmented based on Product (Kits and Test Readers/Analyzers), Platform (Immunoassays, Molecular Detection, and Other Platforms), Application (Blood Glucose Testing, Cardiac Metabolism Testing, Infectious Diseases Testing, Coagulation Testing, Pregnancy & Fertility Testing, Fecal Occult Testing, Hematology Testing, Tumor/Cancer Markers Testing, Drugs Of Abuse Testing, Urinalysis, and Cholesterol Testing), End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self Testing, and Other End Users), and Geography. Insights into Key Segments • Product Segment: In 2022, the kits segment is expected to dominate the rapid diagnostics market, driven by increasing adoption rates and repeated usage of kits. Additionally, the proliferation of disease-specific kits for early chronic disease diagnosis and ongoing technological advancements further bolster this segment's growth. • Platform Segment: The immunoassays platform segment is poised to hold the largest share in 2022, attributed to its ability to deliver rapid and accurate results with high sensitivity, particularly in POC diagnostics. The global demand for precise SARS-CoV-19 testing kits amid the COVID-19 pandemic underscores the significance of immunoassay kits. • Application Segment: Infectious disease testing is forecasted to lead the rapid diagnostics market in 2022, fueled by the escalating prevalence of infectious diseases and the surging demand for affordable testing solutions, especially in emerging markets. • End User Segment: Hospitals & clinics are projected to be the primary end users in 2022, driven by the increasing demand for POC diagnostics and rising healthcare expenditures worldwide. Notably, India's healthcare sector anticipates substantial growth, with government initiatives supporting infrastructure development. Browse in depth @ https://www.meticulousresearch.com/product/rapid-diagnostics-market-5240?utm_source=press-relese&utm_medium=social&utm_campaign=product&utm_content=03-05-2024 Based on product, the kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment. Based on platform, the immunoassays segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is attributed to the capability of immunoassay kits to provide fast and accurate results with high sensitivity in point-of-care diagnostics. Countries worldwide require rapid and accurate SARS-CoV-19 testing kits to tackle the COVID-19 pandemic. Thus, companies have started developing immunoassay kits that provide results with higher sensitivity, accuracy, and speed. For instance, in May 2021, Stream Bio (U.K.) and Chelsea Technologies (U.K.) formed a joint venture, Brightline Diagnostics (DX), and created a unique platform known as Claritas that couples fluorescent lateral flow test with a highly sensitive handheld reader, delivering significant advantages over existing assays. Based on application, the infectious disease testing segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the rising prevalence of infectious diseases and the growing demand for affordable infectious disease testing in emerging markets. For instance, in the U.S., the number of estimated new hepatitis A virus (HAV) infections increased by nearly three folds in 2017 compared to 2014. • In 2019, the number of estimated new hepatitis A virus (HAV) infections rose by approximately 51% compared to the previous year due to the significant increase in the homeless population and the population involved in drug abuse. Similarly, there is a large prevalence of infectious diseases in China. According to China’s Centre for Disease Control (CCDC), the country accounts for 3% of new HIV infections every year and reported over 850,000 people living with HIV. Based on end user, the hospitals & clinics segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing demand for point-of-care diagnostics and the rising healthcare expenditure worldwide. For instance, according to Invest India (National Investment Promotion and Facilitation Agency), the hospital and healthcare industry in India forecasts tremendous growth due to the significant increase in coverage and healthcare spending. In addition, the government announced plans to spend over $200 billion on medical infrastructure by 2024, which will support the establishment of new hospitals & clinics. Buy Now @ https://www.meticulousresearch.com/Checkout/74262428?utm_source= press-relese&utm_medium=social&utm_campaign=product&utm_content=03-05-2024 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri May 03 2024 Hits: 65 Rating: 0.00 Votes: 0) Rate It

• Projected Value of the Pet Oral Care Market: $3 Billion by 2030 - Meticulous Research®, a renowned global market research firm, has unveiled its latest research report titled "Pet Oral Care Market by Product (Toothpaste, Toothbrush, Mouthwash, Chewable, Additives), Animal Type (Dogs, Cats), Sales Channel (e-commerce, Pet Store, Pharmacy, Supermarkets, Veterinary Hospitals), Geography - Global Forecast to 2030." According to the report, the pet oral care market is poised to reach $3 billion by 2030, with a projected compound annual growth rate (CAGR) of 6.1% during the forecast period. This growth is primarily fueled by increasing pet ownership, escalating expenditure on pets and insurance, and the rising incidence of dental issues among pets. Market Overview: The study offers a detailed analysis of the industry, segmented by product, animal type, sales channels, and geography, while also evaluating the global and regional market share of industry competitors. Key Insights: Dental chews are anticipated to witness the highest CAGR, driven by innovations in ingredients and the introduction of new products such as Clear Conscience Pet's plaque-preventive chew infused with Kelp. Dogs are leading the market segment, buoyed by their widespread adoption and growing awareness of oral health, especially in developed nations. Online sales are expected to experience significant growth due to heightened awareness of pet health, increased pet adoption, and the convenience of online transactions. Geographic Analysis: The report provides an in-depth examination of major regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America, propelled by its substantial expenditure and awareness of pet health, is projected to maintain dominance, led by the U.S. Key Players: Prominent players in the market landscape include Boehringer Ingelheim International GmbH, VETOQUINOL S.A., AllAccem, Inc., among others. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=2692 Key Areas Addressed: Identification of high-growth segments within products, animal types, sales channels, and regions. Historical market analysis. Forecasts and estimations for the period 2023–2030. Analysis of drivers, restraints, challenges, opportunities, and trends. Assessment of major players and competitive dynamics. Review of recent developments and adopted strategies. Examination of geographic trends and growth regions/countries. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri May 03 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Unveils Comprehensive Market Analysis Report: 'Label-Free Detection Market - Global Forecast to 2031 - Meticulous Research®, a renowned leader in global market research, has announced the release of its latest research report titled 'Label-Free Detection Market Size, Share, Forecast, & Trends Analysis by Product (Biosensor, Microplate, Microcalorimeter), Technology (SPR, BLI), Process (Binding Kinetic, Lead Generation, Hit Confirmation), Application, End User - Global Forecast to 2031.' Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3408 According to the findings of this comprehensive study, the label-free detection market is anticipated to soar to a valuation of $4.48 billion by 2031, with a remarkable Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period. This growth trajectory is fueled by several factors including the rapid expansion of the pharmaceutical and biotechnology sectors, escalating government initiatives and funding for diverse Research and Development (R&D) endeavors, increasing adoption of avant-garde methodologies in drug discovery, and a burgeoning emphasis on personalized medicine. Additionally, the report underscores the pivotal role played by technological advancements in label-free detection, burgeoning applications of label-free detection in point-of-care testing, and the emergence of promising economies, all of which are poised to offer lucrative growth opportunities within the market. However, the market faces certain challenges such as the prohibitive costs associated with instruments and a shortage of adept professionals capable of handling complex equipment. Furthermore, obstacles related to real-time detection of low-mass small molecules and constraints pertaining to sensitivity and specificity pose additional hurdles to market expansion. Key Market Players The label-free detection market boasts a landscape populated by influential players such as Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE HealthCare Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sartorius AG (Germany), Corning Inc. (U.S.), Horiba, Ltd. (Japan), Malvern Panalytical Ltd (U.K.), and Bruker Corporation (U.S.). Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=3408 Future Outlook The label-free detection market is meticulously segmented based on Product Type, Technology, Application, Process, End User, and Geography. The report not only evaluates industry competitors but also offers a detailed analysis of regional and country-level markets. • Product Type Segmentation: The market is segmented into Consumables (Biosensor Chips, Microplates, Kits & Reagents), Instruments (Optical Biosensor Instruments, Microcalorimeters, Other Instruments), and Software. • Technology Segmentation: The market encompasses a spectrum of technologies including Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI), Isothermal Titration Calorimetry (ITC), Grating-Coupled Interferometry (GCI), Differential Scanning Calorimetry (DSC), and other cutting-edge technologies. • Application Segmentation: Applications span across Drug Discovery & Development, Vaccine Development, Gene Therapy Development, Biological Research, and other pivotal domains. • Process Segmentation: Processes include Binding Kinetics, Hit Confirmation, Lead Generation, Endogenous Receptor Detection, Binding Thermodynamics, and other indispensable processes. • End User Segmentation: End users encompass Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations. Geographical Analysis The report provides a meticulous analysis of major geographies including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. Notably, North America is projected to dominate the label-free detection market in 2024, followed closely by Europe and Asia-Pacific. North America's market supremacy is underpinned by factors such as the presence of key label-free detection entities, advanced healthcare infrastructure, technological innovations in label-free detection methodologies, burgeoning drug discovery initiatives, and ample research funding availability. Quick Buy @ https://www.meticulousresearch.com/Checkout/81435285 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri May 03 2024 Hits: 65 Rating: 0.00 Votes: 0) Rate It

• Projected Value of the Biochemical Reagents Market: $39.61 Billion by 2031 - Meticulous Research®, a prominent global market research company, has released a comprehensive report titled "Biochemical Reagents Market by Type (PCR, Chromatography, Cell & Tissue Culture, Flow Cytometry, Electrophoresis, Immunoassay) End User (Pharmaceutical & Biotechnology, CRO, Diagnostic Laboratories, Food Companies, Academic) – Global Forecast to 2031." In this latest report, Meticulous Research® projects the global biochemical reagents market to reach $39.61 billion by 2031, with a compound annual growth rate (CAGR) of 6.4%. The market's growth is driven by factors such as the increasing demand for biochemical reagents in the pharmaceutical industry, the rising prevalence of chronic diseases, and the continuous expansion of the pharmaceutical and biotechnology sector. Additionally, the utilization of biochemical reagents in forensic and agriculture companies, along with the rising number of diagnostic and pathology laboratories, contributes to market growth. However, concerns regarding reagent cross-contamination pose challenges to market expansion. Despite this, advancements in biochemistry techniques and the rising demand for biochemical reagents for diagnostics present growth opportunities. Nevertheless, the short shelf life of biochemical reagents remains a major challenge. Key Players: The leading players in the global biochemical reagents market include Waters Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Merck KGaA (U.S.), Siemens Healthineers AG (Germany), QIAGEN N.V. (Germany), Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), and Abbot Laboratories (U.S.). Biochemical Reagents Market: Future Outlook The global biochemical reagents market is segmented by Type (PCR Reagents, Chromatography Reagents, Cell & Tissue Culture Reagents, Flow Cytometry Reagents, Electrophoresis Reagents, Immunoassay Reagents, Other Reagents), End User (Pharmaceutical & Biotechnology Companies, CROs & CDMOs, Hospitals, Diagnostic Laboratories, Food & Beverage Companies, Academic & Research Institutes, and Other End Users), and Geography. The report provides a comprehensive analysis of industry competitors and evaluates their market shares globally and regionally. In 2024, the chromatography reagents segment is projected to hold the largest market share among all types of biochemical reagents. This dominance is attributed to the reliability and broad applicability of chromatography techniques across various industries. Similarly, the pharmaceutical & biotechnology segment is expected to account for the largest market share in 2024 among all end users, driven by increased investments in research and development (R&D) and rising funding for pharmaceutical research. Geographic Review: North America is anticipated to lead the biochemical reagents market in 2024, followed by Europe and Asia-Pacific. North America's dominance is attributed to the presence of key players, well-established laboratories, and substantial spending on R&D by pharmaceutical and biotechnology companies. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5778 Key questions addressed in the report: • Which are the high-growth market segments in terms of type, end user, and region/country? • What was the historical market for biochemical reagents across the globe? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, opportunities, and trends in the global biochemical reagents market? • Who are the major players in the global biochemical reagents market? • What is the competitive landscape like, and who are the market leaders in the global biochemical reagents market? • What are the recent developments in the biochemical reagents market? • What are the different strategies adopted by the major players in the biochemical reagents market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email: sales@meticulousresearch.com Contact Sales: +1-646-781-8004 Connect with us on LinkedIn: https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri May 03 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• The Animal Parasiticides Market Projected to Reach $17.9 Billion by 2030 - Meticulous Research®—a leading global market research company, published a research report titled, "Animal Parasiticides Market By Product [Ectoparasiticides (Pour On, Spray, Spot on), Endoparasiticides (Oral, Injectable), Endectocides], Animal (Companion, Livestock), Parasite Type (Tapeworm, Fleas, Ticks, Mites, Roundworms) - Global Forecast to 2030." According to this latest publication from Meticulous Research®, the animal parasiticides market is expected to reach $17.9 billion by 2030, with a projected compound annual growth rate (CAGR) of 7.3% during the forecast period spanning from 2023 to 2030. Market Dynamics: The growth of the animal parasiticides market is fueled by several factors, including the increasing prevalence of zoonotic and parasitic diseases, rising demand for animal-derived food products, and escalating expenditure on animal health. Additionally, the expanding number of livestock in emerging economies presents significant growth opportunities for this market. Challenges: Despite the promising growth outlook, challenges such as the restricted use of parasiticides in food-producing animals pose a notable hindrance to market expansion. Moreover, the growing inclination towards vegetarian and vegan diets represents a major challenge for market growth. Animal Parasiticides Market: Future Outlook The animal parasiticides market is segmented by product type, parasite type, animal type, and geography. The report provides a detailed analysis of industry competitors and evaluates the market at both country and regional levels. Based on product type, the ectoparasiticides segment is expected to hold the largest market share of the animal parasiticides market in 2023. This dominance is attributed to factors such as the high incidence of fleas, ticks, and mites infestations in animals, as well as the ease of administering ectoparasiticides to companion and farm animals through various forms such as liquid pours, spots, sprays, powders, collars, and ear tags. Based on parasite type, the mite, tick, flea, lice, and grub infestation segment is projected to dominate the animal parasiticides market in 2023. This is primarily due to the high prevalence of ectoparasitic infections in animals, as they serve as a food source for external parasites like fleas, ticks, and lice, which can embed themselves in animals’ fur to lay eggs. Based on animal type, the companion animal segment is expected to hold the largest market share in 2023. This is attributed to the large population of pets globally, with many households treating pets as family members and showing a willingness to invest in their health. Geographic Analysis: In 2023, North America is anticipated to lead the animal parasiticides market, followed by Europe and Asia-Pacific. This market dominance in North America is driven by factors such as high expenditure on animal health, a highly commercialized and institutionalized meat industry, substantial consumption and import-export of animal-derived food products, and a large population of pets treated as family members. Key Players: Major players operating in the animal parasiticides market include Zoetis Inc. (U.S.), Virbac (France), Heska Corporation (U.S.), Bimeda, Inc. (Ireland), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (U.S.), Elanco Animal Health Incorporated (U.S.), Vetoquinol Group (France), PetIQ, LLC (U.S.), and ECO Animal Health Ltd (U.K.), among others. Download PDF Brochure @ https://www.meticulousresearch.com/download-sample-report/cp_id=5451 Key Questions Addressed: • What are the high-growth market segments in terms of product type, animal type, parasite type, and region/country? • What was the historical market size for animal parasiticides across the globe? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the global animal parasiticides market? • Who are the major players operating in the animal parasiticides market? • How is the competitive landscape, and who are the market leaders in the global animal parasiticides market? • What recent developments have occurred in the global animal parasiticides market? • What are the different strategies adopted by the major players in the global animal parasiticides market? • What are the geographical trends and high-growth regions/countries? ContactUs: MeticulousResearch® Email- sales@meticulousresearch.com ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Thu May 02 2024 Hits: 63 Rating: 0.00 Votes: 0) Rate It

• Charting Growth: Top 10 Companies Making Waves in the Spatial Genomics Industry - The global Spatial Genomics Market is anticipated to achieve a remarkable valuation of $3.23 billion by 2031, exhibiting an impressive Compound Annual Growth Rate (CAGR) of 27.8% during the forecast period. This projection, as highlighted by Meticulous Research®, underscores the burgeoning significance of spatial genomics & transcriptomics in the study of genetic expression within native spatial contexts. 🚀 Key Drivers Market Expansion Spatial genomics, integrating in situ hybridization techniques with molecular biology tools like next-generation sequencing, finds diverse applications in developmental biology, oncology, neurology, immunology, and beyond. The market's growth is propelled by its increasing utility in drug discovery & development, cancer research, biomarker detection, and its role in addressing the rising prevalence of cancer. Despite these growth drivers, challenges such as the lack of standardized genomics approaches and concerns over data security and privacy pose constraints to market expansion. Nevertheless, opportunities abound with the rising adoption of personalized medicines & gene therapies and escalating investments in spatial genomics. For more information on this groundbreaking report : https://meticulousblog.org/top-10-companies-in-spatial-genomics-market/ Here are the top 10 companies operating in the Spatial Genomics Market: 10X Genomics, Inc. (U.S.) :10X Genomics, Inc., headquartered in California, U.S., pioneers advancements in biomedicine through integrated solutions catering to COVID-19, immunology, cancer, neuroscience, and drug discovery. NanoString Technologies, Inc. (U.S.) :NanoString Technologies, Inc., based in Washington, U.S., develops life science tools leveraging digital molecular barcoding technology for clinical research and molecular diagnostics. Akoya Biosciences, Inc. (U.S.) :Akoya Biosciences, Inc., headquartered in Massachusetts, U.S., offers single-cell imaging solutions for phenotyping cells in spatial contexts, aiding comprehensive spatial biology analysis. Illumina, Inc. (U.S.) :Illumina, Inc., incorporated in California, U.S., provides sequencing and array-based solutions for genomic and genetic analysis, playing a pivotal role in spatial genomics applications. Oxford Nanopore Technologies Plc. (U.K.) :Oxford Nanopore Technologies Plc., based in England, U.K., pioneers nanopore-based sequencing platforms enabling real-time DNA/RNA analysis. Revvity, Inc. (U.S.) :Revvity, Inc., headquartered in Massachusetts, U.S., delivers products and solutions for life sciences and diagnostics, with a focus on spatial genomics applications. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5763 S2 Genomics, Inc. (U.S.) :S2 Genomics, Inc., based in California, U.S., develops spatial sequencing technology solutions for single-cell genomics and cell biology studies. Cantata Bio (U.S.) : Cantata Bio, headquartered in California, U.S., offers NGS-based products and services, including genetic analysis solutions for spatial genomics applications. Vizgen Inc. (U.S.) :Vizgen Inc., based in Massachusetts, U.S., develops spatially resolved transcriptomic profiling tools, providing insights into biological systems. Biospyder Technologies Inc. (U.S.) :Biospyder Technologies Inc., headquartered in California, U.S., offers next-generation spatially resolved transcriptomic profiling tools for high-throughput gene monitoring. About Meticulous Research: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Thu May 02 2024 Hits: 96 Rating: 0.00 Votes: 0) Rate It

• Latin America NGS Market to be Worth $765.2 Million by 2031 - Meticulous Research®, a renowned global market research firm, has unveiled its latest report titled "Latin America NGS Market - Forecast to 2031," offering comprehensive insights into the NGS landscape in the region. Here's a breakdown of the key findings: Market Projection: The Latin America NGS market is poised to achieve a significant milestone, reaching $765.2 million by 2031, with a robust CAGR of 13.9% from 2024 to 2031. Factors driving this growth include governmental and organizational initiatives for genomic sequencing projects, advancements in sequencing techniques, declining costs of genome sequencing, and the expanding applications of NGS in cancer treatment and research. Market Dynamics: While the market exhibits promising growth prospects, challenges such as the high costs of NGS systems and consumables and the presence of alternative technologies may hinder its expansion. However, the rising adoption of bioinformatics solutions and collaborations to support next-generation sequencing present growth opportunities. Get Free Sample Report: https://www.meticulousresearch.com/download-samplereport/cp_id=5780?utm_source=article&utm_medium=social&utm_campaign=product&utm_ content=30-04-2024 Key Players: Major players in the Latin America NGS market include Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Plc., and 10X Genomics, Inc. Market Segmentation: The report segments the market based on offering, sequencing type, technology, application, end user, and geography, offering detailed insights into each segment's growth trajectory and market dynamics. Future Outlook: The report provides a comprehensive analysis of the market's future outlook, identifying growth opportunities, challenges, and emerging trends that stakeholders can leverage to make informed decisions and drive business growth. Geographic Analysis: Brazil is expected to lead the Latin America NGS market in 2024, driven by factors such as the adoption of advanced technologies for research purposes, expanding applications of NGS in drug discovery, and the rising incidence of chronic diseases. For organizations looking to capitalize on the burgeoning Latin America NGS market, Meticulous Research®'s report serves as a valuable resource, offering actionable insights and strategic recommendations.  ^update (Added: Tue Apr 30 2024 Hits: 67 Rating: 0.00 Votes: 0) Rate It

• Top 10 Companies in the Pharmacogenomics Market - The Pharmacogenomics Market is on track to achieve substantial growth, with forecasts indicating a valuation of $19.5 billion by 2031, marking a robust CAGR of 8.9% during the forecast period from 2024 to 2031. This market encompasses consumables, instruments, and software & services and is propelled by several key factors including the expanding therapeutic applications of pharmacogenomic biomarkers, the increasing adoption of personalized medicines, and demographic shifts such as the rising geriatric population and the prevalence of chronic diseases. Furthermore, regulatory recommendations from bodies like the U.S. FDA and EMA advocating for the utilization of pharmacogenomic data in drug discovery & development are driving market growth. Key Drivers: Additional growth drivers include the escalating application of pharmacogenomics in treating neurological disorders and cancers, the development of advanced diagnostic tools with enhanced accuracy, and the growing awareness regarding adverse drug reactions. These factors are expected to present significant growth opportunities for stakeholders in the pharmacogenomics market. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-pharmacogenomics-market/ Here are the top 10 companies at the forefront of innovation in the Pharmacogenomics Market: 1. Thermo Fisher Scientific Inc. (U.S.): Thermo Fisher offers a wide range of products and services across various sectors, including pharmaceuticals and biotechnology. The company's offerings in the pharmacogenomics market include PCR, sequencing, and microarray solutions. 2. Agilent Technologies, Inc. (U.S.): Agilent Technologies specializes in testing and technology innovation, providing software, consumables, services, and instruments for laboratory workflow. Its pharmacogenomics solutions cover diagnostics, genomics, and life sciences. 3. Illumina, Inc. (U.S.): Illumina is a leading provider of sequencing- and array-based solutions for genomic and genetic analysis. The company's Core Illumina segment offers instruments, consumables, and software for the pharmacogenomics market. 4. Qiagen N.V. (Netherlands): Qiagen is a prominent provider of sample and assay technologies for molecular diagnostics and research. Its pharmacogenomics products include PCR consumables, diagnostic solutions, and genomics/NGS solutions. 5. Danaher Corporation (U.S.): Danaher Corporation is a science and technology company operating in various sectors, including life sciences and diagnostics. Its pharmacogenomics products cover instruments, genomic sample preparation, and consumables. 6. Bio-Rad Laboratories, Inc. (U.S.): Bio-Rad Laboratories develops, manufactures, and markets products for life science research and clinical diagnosis. Its pharmacogenomics solutions include purification, separation, and amplification of genetic material. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5366 7. PerkinElmer, Inc. (U.S.): PerkinElmer offers products, solutions, and services for life sciences, diagnostics, and applied markets. Its pharmacogenomics offerings include mass spectrometry solutions, NGS consumables, and nucleic acid isolation solutions. 8. F. Hoffmann-La Roche (Switzerland): F. Hoffmann-La Roche is a research-based healthcare company offering innovative medicines and diagnostic solutions. Its pharmacogenomics products include companion diagnostic assays and sequencing instruments. 9. Pacific Biosciences of California, Inc. (U.S.): Pacific Biosciences designs, develops, and manufactures sequencing solutions for complex genetic analysis. Its pharmacogenomics offerings include sequencing systems and consumables. These companies are at the forefront of driving innovation and shaping the future of the pharmacogenomics market, addressing the evolving needs of patients and healthcare providers worldwide. About Meticulous Research: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Tue Apr 30 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

• Top 10 Companies in the Europe Cancer Diagnostics Market - The Europe Cancer Diagnostics Market is poised for robust growth, with a projected CAGR of 5.6% during the forecast period, reaching an estimated value of $12.21 billion by 2031. Cancer diagnostics encompass a range of in vitro diagnostics and imaging tests crucial for detecting various types of cancer, including breast, lung, prostate, colorectal, and others. These tests play a pivotal role in identifying cancer, guiding treatment decisions, predicting cancer recurrence risk, monitoring treatment efficacy, and characterizing cancer type and stage. This report offers a comprehensive assessment of products used in cancer diagnosis, including kits & reagents, imaging instruments, and IVD instruments, among others. Market Growth & Analysis: The market's growth is fueled by factors such as the increasing prevalence of cancer, initiatives supporting early cancer detection, rising awareness, escalating investments and funding for cancer research, and technological advancements. Additionally, initiatives promoting precision diagnostics for cancer are expected to create growth opportunities for players in the Europe cancer diagnostics market. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-europe-cancer-diagnostics-market/ Here are the top 10 companies leading the Europe Cancer Diagnostics Market: 1. Thermo Fisher Scientific Inc. (U.S.): A pioneer in life sciences research since 1956, Thermo Fisher Scientific Inc. operates through four segments, including Life Science Solutions and Specialty Diagnostics, offering cancer diagnostics reagents, instruments, and consumables globally. 2. F. Hoffmann-La Roche Ltd (Switzerland): Established in 1896, F. Hoffmann-La Roche Ltd develops, manufactures, and markets healthcare solutions, operating in the cancer diagnostics market through its Diagnostics segment. 3. QIAGEN N.V. (Netherlands): Founded in 1984, QIAGEN N.V. develops and sells instruments, consumables, and digital bioinformatics solutions for oncology, infectious diseases, and precision diagnostics. 4. Abbott Laboratories (U.S.): In operation since 1900, Abbott Laboratories offers a range of healthcare products, including diagnostic tests, kits, and panels for cancer testing, through its Diagnostic Products business segment. 5. llumina, Inc. (U.S.): Incorporated in 1998, Illumina, Inc. provides sequencing and array-based solutions for genomic and genetic analysis, including cancer diagnostics kits and reagent panels. 6. Canon Medical Systems Corporation (Japan): Established in 1930, Canon Medical Systems Corporation manufactures diagnostic imaging systems, including those used in cancer diagnostics. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5787 7. Siemens Healthineers AG (Germany): Founded in 1847, Siemens Healthineers AG develops, designs, and distributes imaging systems, scanners, and cancer tests for cancer diagnosis. 8. GE HealthCare Technologies Inc. (U.S.): Formed in 2023 as a separate entity, GE HealthCare Technologies Inc. offers imaging instruments and consumables for cancer diagnostics through its Imaging, Ultrasound, and Pharmaceutical Diagnostics segments. 9. Koninklijke Philips N.V. (Netherlands): Established in 1891, Koninklijke Philips N.V. provides healthcare, consumer lifestyle, and lighting products, offering cancer diagnostics imaging systems and software through its Diagnosis & Treatment segment. 10. FUJIFILM Holdings Corporation (Japan): Founded in 1934, FUJIFILM Holdings Corporation manufactures healthcare solutions and imaging solutions, including products for cancer diagnostics through its Medical Systems segment. These companies are at the forefront of innovation and are driving advancements in cancer diagnostics, ultimately leading to improved patient outcomes and healthcare efficacy in Europe. About Meticulous Research: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Tue Apr 30 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• The Electrosurgery Market is expected to reach $8.99 billion by 2031 - The Electrosurgery Market is on course for significant growth, projected to achieve a valuation of $8.99 billion by 2031, exhibiting a robust Compound Annual Growth Rate (CAGR) of 4.8% from 2024 to 2031. This expansion is fueled by several factors including the increasing number of surgical procedures, the growing preference for minimally invasive techniques, and the rising adoption of computer-assisted surgeries. Moreover, the emergence of medical tourism, particularly in developing nations, and the rising incidence of cancer and chronic diseases, further contribute to market growth. However, challenges such as procedural risks and the shortage of skilled surgeons present hurdles to market progression. Additionally, concerns regarding the release of toxic fumes during electrosurgical procedures pose a notable challenge to market expansion. Key Market Players The Electrosurgery Market is shaped by leading companies dedicated to advancing medical technology and improving patient outcomes. Among the top 10 players are: Among the top10 players shaping the market landscape are: https://meticulousblog.org/top-10-companies-in-electrosurgery-market/ 1. Medtronic plc (Ireland): A renowned healthcare technology company established in 1949, offering diverse biomedical engineering products, including electrosurgery solutions, across 150+ countries. 2. Johnson & Johnson (U.S.): A pioneer in healthcare research, development, and manufacturing since 1887, delivering cutting-edge electrosurgical products globally through its MedTech segment and subsidiary Ethicon Inc. 3. Stryker Corporation (U.S.): At the forefront of providing medical technology products and services since 1941, focusing on improving patient outcomes with a comprehensive range of electrosurgery solutions. 4. CONMED Corporation (U.S.):Specializing in manufacturing and marketing surgical equipment since 1970, offering a wide array of electrosurgery products under its General Surgery category. 5. Olympus Corporation (Japan): A global leader in precision machinery and instruments since 1919, offering advanced electrosurgery products through its Therapeutic Solutions segment. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5396 6. STERIS plc (Ireland): Dedicated to providing infection prevention and procedural products since 1985, offering vital electrosurgery solutions for operating rooms worldwide. 7. Boston Scientific Corporation (U.S.): A key player in developing medical devices since 1979, providing innovative electrosurgery products to healthcare facilities globally through its MedSurg segment. 8. B. Braun SE (Germany): Committed to developing, manufacturing, and marketing medical technology-based products since 1966, offering a comprehensive range of electrosurgery solutions worldwide. 9. BOWA-electronic GmbH & Co. KG (Germany): Specializing in providing energy-based surgical systems since 1977, offering advanced electrosurgical equipment to healthcare providers globally. 10. Erbe Elektromedizin GmbH (Germany): A leading provider of electrosurgery, vessel sealing, and other surgical systems since 1851, setting industry standards in electrosurgical technologies across 110 countries. These companies are pivotal in driving innovation and setting industry standards in electrosurgical technologies. Insights from Meticulous Research Meticulous Research, in its latest publication on the Electrosurgery Market, has forecasted a growth rate of 4.8% during the forecast period 2024-2031, reaffirming the market's potential for expansion. About Us: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Mon Apr 29 2024 Hits: 80 Rating: 0.00 Votes: 0) Rate It

• Middle East & Africa Molecular Diagnostics Market to be Worth $1.16 Billion by 2031 - Meticulous Research®—a leading market research company, published a research report titled, ‘Middle East & Africa Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software) Test Type (Lab, PoC) Technology (PCR, ISH, INAAT, Sequencing, Microarray) Application (Influenza, HPV, Oncology, Gene Testing) End User - Forecast to 2031’ According to this latest publication from Meticulous Research®, the Middle East & Africa molecular diagnostics market is projected to reach $1.16 billion by 2031, at a CAGR of 5.4% from 2024 to 2031. The growth of the Middle East & Africa molecular diagnostics market is driven by factors such as the rising prevalence of communicable and non-communicable diseases, technological advancements in molecular diagnostics, increasing investments and funding aimed at enhancing healthcare systems in the Middle East & Africa, and the rising healthcare expenditure in the region. However, inconsistencies in medical device regulations across the Middle East & Africa and the high costs of molecular diagnostic tests restrain the market’s growth. Emerging medical and wellness tourism in the UAE and a growing focus on companion diagnostics are expected to create market growth opportunities. However, the shortage of skilled professionals poses a significant challenge to the growth of this market. Key Players The key players profiled in the Middle East & Africa molecular diagnostics market report are AstraGene LLC (U.A.E.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Illumina, Inc. (U.S.), AstraZeneca Gulf FZ LLC (Dubai), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S), and Agilent Technologies, Inc. (U.S.). The Middle East & Africa molecular diagnostics market is segmented by Offering (Kits & Reagents, Instruments, Software & Services), Test Type (Laboratory Tests and Point-of-Care [POC] Tests), Technology (Polymerase Chain Reaction [PCR], In Situ Hybridization [ISH], Isothermal Nucleic Acid Amplification Technology [INAAT], Microarrays, Sequencing, Mass Spectrometry, and Other Technologies), Application (Infectious Diseases [Respiratory Diseases, Hepatitis, HIV, Chlamydia Trachomatis/Neisseria Gonorrhoeae, Human Papillomavirus {HPV}, Healthcare-Associated Infections {HAIs}, and Other Infectious Diseases], Oncology [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Lymphoma, Leukemia, Cervical Cancer, and Other Cancer Types], Genetic Testing, Neurological Diseases, Cardiovascular Diseases, and Other Applications), End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Other End Users), and geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. Among the offerings studied in this report, in 2024, the kits and reagents segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the wide availability of a diverse range of diagnostic reagents & consumables and the growing awareness regarding the importance of early disease diagnosis. For instance, in September 2023, the World Health Organization (WHO) Regional Office for Africa, along with the support of F. Hoffmann-La Roche Ltd. (Switzerland), launched an initiative in Cote d’Ivoire, Kenya, and Zimbabwe to provide health promotion, detection, screening, and early diagnosis and treatment of breast and cervical cancer. This initiative was aimed at providing an integrated and holistic system of healthcare that will contribute to addressing the burden of breast and cervical cancer in the African region. Among the test types studied in this report, in 2024, the laboratory test segments is expected to account for the largest share of the market. The large market share of this segment can be attributed to the substantial number of laboratory tests conducted in hospitals and laboratories due to the high accuracy of the test results. Furthermore, the expansion and enhancement of diagnostic laboratory networks in the region also contribute to the segment's significant market share. For instance, in December 2021, 54gene (Nigeria) launched a chain of diagnostic labs named 7RiverLabs. These labs are equipped with state-of-the-art technology, offering world-class, cost-effective, speedy, reliable, and advanced molecular diagnostics to healthcare providers and patients. Among the technologies studied in this report, in 2024, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the high specificity and sensitivity of the instrument, along with technological advancements in PCR technology. Additionally, the improved PCR testing capabilities in laboratories and the introduction of new products during the COVID-19 pandemic to address the growing burden contribute to the growth of this segment. For instance, in February 2022, F. Hoffmann-La Roche Ltd. (Switzerland) expanded its COVID-19 PCR portfolio with the introduction of the cobas 5800 system in countries accepting the CE mark. This expansion includes the cobas SARS-CoV-2 Qualitative and cobas SARS-CoV-2 & Influenza A/B tests, offering standardized performance and efficiencies in addressing various molecular laboratory testing needs across low, medium, and high volumes. Among the applications studied in this report, in 2024, the infectious diseases segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the growing prevalence of infectious diseases and the rise in funding allocated for the development of new diagnostic tools for infectious diseases. According to the World Health Organization (WHO), in 2022, there were a total of 249 million cases of malaria worldwide, with the African region accounting for 94% of these cases. The rising incidence of such infections drives the demand for rapid, user-friendly, and cost-effective infectious disease testing tools. Among the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the market. The large market share of this segment can be attributed to the increased number of hospitalizations due to various diseases that necessitate molecular diagnosis. Additionally, the proliferation of hospitals and clinics in emerging countries contributes to the growing utilization of molecular diagnostic products. The expansion of hospitals in the Middle East & Africa further drives the demand for molecular diagnostic tests. For instance, in April 2023, Burjeel Holdings (UAE.) partnered with OncoHelix, Inc. (U.S.) to establish a state-of-the-art laboratory in Abu Dhabi (UAE), offering advanced molecular diagnostics, cellular, and immunological profile testing for patients in the UAE. Among the countries studied in this report, in 2024, Saudi Arabia is expected to account for the largest share of the market. The large market share of this segment can be attributed to factors such as the high disease burden of both communicable and non-communicable diseases, the widespread adoption of molecular diagnostics in laboratory tests, ongoing improvements in the healthcare infrastructure, and rising healthcare expenditure. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5791 Key questions answered in the report: • Which are the high-growth market segments in terms of molecular diagnostics in the Middle East & Africa by offering, test type, technology, application, end user, and geography? • What was the historical market for molecular diagnostics across the Middle East & Africa? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, opportunities, and challenges in the Middle East & Africa molecular diagnostics market? • Who are the major players in the Middle East & Africa molecular diagnostics market? • What is the competitive landscape like, and who are the market leaders in the Middle East & Africa molecular diagnostics market? • What are the recent developments in the Middle East & Africa molecular diagnostics market? • What are the different strategies adopted by the major players in the Middle East & Africa molecular diagnostics market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Mon Apr 29 2024 Hits: 55 Rating: 0.00 Votes: 0) Rate It

• Protein Assays Market to be Worth $4.36 Billion by 2031 - Meticulous Research®—a leading global market research company, published a research report titled, ‘Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital) – Global Forecast to 2031’ According to this latest publication from Meticulous Research®, the global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% from 2024 to 2031. The growth of this market can be attributed to various factors, such as increasing pharmaceutical R&D expenditure, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth. Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are a major challenge for the market’s growth. Key Players The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.). Protein Assays Market: Future Outlook The global protein assays market is segmented by Offering (Reagents & Kits and Instruments & Accessories), Type (Dye-based Assay, Copper-based Assay, and Other Assay Types), Technology (Fluorescence-based Protein Assay, Absorbance-based Protein Assay, and Colorimetric-based Protein Assay), Application (Drug Discovery, Research & Development, Clinical Diagnosis, and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Food & Beverage Companies, Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares at the global and regional levels. Among all the offerings studied in this report, in 2024, the reagents & kits segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increasing use of protein assays reagents & kits for accurate and faster results. Additionally, the wide availability of consumables, recurring use of protein assay kits, and increasing adoption of these kits by researchers to estimate protein concentration in unknown samples are contributing to the largest share of the segment. Among all the types studied in this report, in 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the rapid results with the dye-based assays enabling testing of a high number of samples in a short time, and the test uses visible light for the detection, so no special instrumentation is required. Additionally, the reagents used in the assays do not cross-react with each other thus, the reliability of the method increases, and increasing use of dye-binding assays in the determination of residual protein content in biological processes such as cell lysis is contributing to the largest share of the segment. Among all the technologies studied in this report, in 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the absorbance method is an accepted choice for researchers, has less sample consumption, is simple to perform, and requires no additional or hazardous reagents or standards. Additionally, absorbance is considered the best measurement method for the quantification of pure protein samples, further supporting the largest share of the segment. Among all the applications studied in this report, in 2024, the drug discovery segment is expected to account for the largest share of the protein assays market. The largest share of the segment is attributed to the increased use of protein assay in life science research, as quantification of proteins is a primary requirement for many downstream processes such as structural analysis, immunochemical techniques, protein separation, and chromatographic techniques, which can further be employed into drug discovery & development process. Among all end users studied in this report, in 2024, the pharmaceutical & biotechnology segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the growing number of research and clinical laboratories, increased investments in R&D, and rising funding for pharmaceutical research. The rising demand for new drugs and therapies is driving an increase in funding for research laboratories, consequently creating a higher demand for protein assays. For instance, NIH funding has witnessed an increase from USD 42 billion in 2021 to USD 45 billion in 2022 for research purposes (Source: Congressional Research Service). This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. Among all regions studied in this report, in 2024, North America is expected to account for the largest share of the protein assays market. North America’s major market share is attributed to the presence of key players, well-established research and clinical laboratories, and substantial spending on R&D by pharmaceutical and biotechnology companies. Additionally, the expansion of research and clinical laboratories by the key players is supporting the largest regional share. For instance, in October 2022, Thermo Fisher Scientific Inc. (U.S.) is expanding its clinical research lab in Kentucky, U.S., with an investment of USD 59 million. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5803 Key questions answered in the report- • Which are the high-growth market segments in terms of offering, type, technology, application, end user, and region/country? • What was the historical market for protein assays across the globe? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, opportunities, and trends in the global protein assays market? • Who are the major players in the global protein assays market? • What is the competitive landscape like, and who are the market leaders in the global protein assays market? • What are the recent developments in the protein assays market? • What are the different strategies adopted by the major players in the protein assays market? • What are the geographical trends and high growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri Apr 26 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Healthcare IT Market to be Worth $907.18 Billion by 2031 - Meticulous Research®—a leading global market research company, published a research report titled ‘Healthcare IT Market by Product (EHR, CDSS, CPOE, Telehealth, Financial Analytics, Claims Management Services, mhealth, RCM, Analytics, CRM, Population Health, LIS, PACS, VNA) Deployment Mode (On-Premise, Cloud) Component & End User - Global Forecast to 2031’ According to this latest publication from Meticulous Research®, the healthcare IT market is projected to reach $907.18 billion by 2031 at a CAGR of 13.2% during the forecast period. The growth of the healthcare IT market is driven by rising awareness regarding digital health, government mandates and incentives for healthcare IT and infrastructure development, the shift toward value-based care, the growing utilization of big data in the healthcare sector, the high returns on IT investments in the healthcare industry, and the increasing number of patient visits. However, the high costs of implementing and maintaining healthcare IT infrastructure, financial constraints in developing countries, and restricted budgets of small and medium-sized healthcare facilities restrain the growth of this market. Additionally, the growing focus on cloud-based solutions, the rising adoption of AI & IoT technologies in healthcare, and emerging economies such as India and China with increasing per capita healthcare expenditures are expected to offer significant growth opportunities for the stakeholders in this market. However, interoperability issues, data security & privacy concerns, and the shortage of trained IT professionals are major challenges impacting the market's growth. Moreover, the increasing use of Virtual Reality (VR) and Augmented Reality (AR) for physical and surgical procedures, the increasing demand for healthcare IT solutions in the field of genomics and personalized medicine, increasing access to virtual hospitals, and the rising demand for remote patient monitoring and telemedicine solutions are prominent trends in the healthcare IT market. Key Players: The key players operating in the healthcare IT market are International Business Machine Corporation (IBM) (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Infor, Inc. (A Subsidiary of Koch Industries, Inc. (U.S.), Cognizant Technology Solutions Corporation (U.S.), Oracle Corporation (U.S.), athenahealth, Inc. (A Subsidiary of Veritas Capital) (U.S.), Dell Technologies, Inc. (U.S.), Unitedhealth Group (Optum, Inc.) (U.S.), Nuance Communications, Inc. (U.S.), 3M Company (U.S.), Conifer Health Solutions, LLC. (A subsidiary of Tenet Healthcare Corporation (U.S.)), NextGen Healthcare, Inc. (A subsidiary of Thoma Cressey Bravo, Inc. (U.S.)), PointClickCare Technologies Inc. (U.S.), and eClinicalWorks (U.S.). Healthcare IT Market: Future Outlook The Healthcare IT market is segmented based on Product (Healthcare IT Provider Solutions [{Clinical Healthcare IT Solutions, Electronic Health Records (EHR), PACS & VNA, Computerized Physician Order Entry (CPOE) Solutions, Clinical Decision Support Systems (CDSS), E-Prescribing Systems, Patient Engagement Solutions, RIS (Radiology Information Systems), RDM (Radiation Dose Management) Solutions, Specialty Information Systems, Medical Image Analysis, Population Health Management Solutions, Care Management Solutions, Patient Registry Software, Laboratory Information Systems (LIS), health Solutions, Telehealth, Healthcare Integration Solutions, Infection Surveillance Solutions, Practice Management Software], Non-Clinical Provider Healthcare IT Solutions [Pharmacy Information Systems, Healthcare Asset Management Solutions, Healthcare Workforce Management Solutions, Revenue Cycle Management Solutions {Front-End RCM, Mid-End RCM, Back-End RCM}, Medical Document Management Solutions, Healthcare Information Exchanges, Supply Chain Management Solutions, Healthcare Analytics {Clinical Analytics, Financial Analytics, Operational & Administrative Analytics}, Customer Relationship Management Solutions {Medication Management Systems (Electronic Medication Administration Systems, Barcode Medication Administration Systems, Medication Inventory Management Systems, Medication Assurance Systems), Healthcare Quality Management Solutions, Healthcare Interoperability Solutions, Financial Management Solutions (Accounting & Billing)}], Healthcare IT Payer Solutions (Claims Management Solutions, Customer Relationship Management, Fraud Analytics Solutions, Provider Network Management, Pharmacy Audit & Analysis Solutions, Member Eligibility Management Solutions, Population Health Management Solutions, Payment Management Solutions), Healthcare IT Outsourcing Solutions (Provider HCIT Outsourcing Services {Revenue Cycle Management Services, EMR/Medical Document Management Services, Laboratory Information Management Services, Other Provider HCIT Outsourcing Services}, Payer HCIT Outsourcing Services {Claims Management Services, Provider Network Management Services, Billing & Accounts Management Services, Fraud Analytics Services, Other Payer HCIT Outsourcing Services}, Operational HCIT Outsourcing Services {Business Process Management Services, Supply Chain Management Services, Other Operational IT Outsourcing Services, IT Infrastructure Management Services}), by Deployment Mode (Web & Cloud-Based, On-Premise), by Component (Services, Software, Hardware), by End User (Healthcare Providers {Hospitals, Ambulatory Centres, Home Healthcare & Assisted Living Centres, Diagnostic Centres, Pharmacies}, Healthcare Payers {Private Payers, Public Payers}), and geography. The study also evaluates industry competitors and analyses the market at the regional and country levels. Based on product, the healthcare IT market is segmented into healthcare IT provider solutions, healthcare IT payer solutions, and healthcare IT outsourcing services. In 2024, the healthcare IT provider solutions segment is expected to account for the largest share of the healthcare IT market. The large market share of this segment is attributed to factors such as a growing focus on patient safety & care, the increasing demand for integrated healthcare systems, and changing regulatory requirements for healthcare providers. Furthermore, in 2024, the Electronic Health Records (EHRs) segment is expected to account for the largest share of the healthcare IT provider solutions market. The large market share of this segment can be attributed to the high adoption of EHRs, especially in developed countries like the U.S. Based on deployment mode, the healthcare IT market is segmented into web & cloud-based and on-premises. In 2024, the web & cloud-based is expected to account for the larger share of the healthcare IT market. The large market share of this segment can be attributed to the benefits offered by web & cloud-based deployment, including on-demand self-service, minimal maintenance costs, lower upfront and storage costs, and storage flexibility. Moreover, the enhanced security features in private clouds and automated updates in web and cloud solutions are anticipated to drive the growth of this segment. Based on component, the healthcare IT market is segmented into services, software, and hardware. In 2024, the services segment is expected to account for the largest share of the healthcare IT market. The large market share of this segment can be attributed to the shift towards cloud-based services, the need to reduce healthcare expenses, and the high adoption of digital solutions in healthcare facilities. Additionally, the rising need to minimize paperwork and the increasing demand for convenient and cost-effective healthcare access are contributing to the growth of this segment. Based on end user, the healthcare IT market is segmented into healthcare providers and healthcare payers. In 2024, the healthcare providers segment is expected to account for the larger share of the healthcare IT market. The large market share of this segment is primarily attributed to the rising patient volume, increasing healthcare spending, rising awareness about electronic health records, growing geriatric population, and increasing adoption of healthcare IT solutions by healthcare providers. Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the healthcare IT market, followed by Europe and Asia-Pacific. Furthermore, in 2024, the U.S. is expected to be the largest market shareholder in North America. The country’s significant market share can be attributed to the rising adoption of advanced technologies among healthcare providers in the U.S., the high adoption of various healthcare IT solutions by healthcare providers to ensure compliance with stringent regulatory requirements for patient care and safety, the need to mitigate rising healthcare costs, the presence of prominent HCIT vendors in the region, and the growing emphasis on enhancing healthcare quality while optimizing the operational efficiency of healthcare organizations. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5084 Key questions answered in the report: • Which are the high-growth market segments in terms of product, deployment mode, component, end user, and region/country? • What was the historical market size for healthcare IT across the globe? • What are the market forecasts and estimates for 2024–2031? • What are the major drivers, restraints, opportunities, and trends in the global healthcare IT market? • Who are the major players in the global healthcare IT market? • What is the competitive landscape like, and who are the market leaders in the global healthcare IT market? • What are the recent developments in the healthcare IT market? • What strategies are adopted by the major players in the healthcare IT market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri Apr 26 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• Portable Ultrasound Market - Global Opportunity Analysis and Industry Forecast (2024-2031) - Meticulous Research®—a leading global market research company, published a research report titled, ‘Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology), End User (Hospitals, ACC, Imaging Center) – Global Forecast to 2031.’ Download Free Sample: https://www.meticulousresearch.com/download-samplereport/cp_id=5800?utm_source=PR&utm_medium=social&utm_campaign=product &utm_content=25-04-2024 According to this latest publication from Meticulous Research®, the global Portable Ultrasound Market is projected to reach $3.8 billion by 2031, at a CAGR of 7.9% during the forecast period 2024–2031. The growth of the portable ultrasound market is driven by factors such as the growing adoption of portable medical devices in emergency care settings, the proliferation of hospitals, and the increasing demand for handheld ultrasound devices in ambulatory care centers and dialysis centers. The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals and the rising demand from emerging economies are expected to create growth opportunities for players operating in this market. However, factors such as the shortage of skilled professionals, inadequate training programs for healthcare professionals on the use of portable ultrasound devices, reimbursement irregularities, poor image quality, and integration issues of portable ultrasound devices with existing digital health infrastructure pose challenges to the market's growth. Key Players The key players operating in global Portable Ultrasound Market are GE Healthcare Technologies Inc. (U.S.), Siemens Healthineers AG (Germany), Shenzhen Mindray BioMedical Electronics Co., Ltd. (China), Koninklijke Philips N.V., (Netherlands), Samsung Medison Co. Ltd. (A subsidiary of Samsung Electronics Co. Ltd.) (South Korea), FUJIFILM Sonosite, Inc. (A subsidiary of FUJIFILM Holdings Corporation) (U.S.), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Esaote S.p.A (Italy), EDAN Instruments, Inc. (China), EchoNous, Inc. (U.S.), Butterfly Network, Inc. (U.S.), Konica Minolta, Inc. (Japan), CHISON Medical Technologies Co., Ltd (China), SonoScape Medical Corp. (China), and Healcerion Co., Ltd. (South Korea). Browse in Depth: https://www.meticulousresearch.com/product/portableultrasound-market- 5800?utm_source=PR&utm_medium=social&utm_campaign=product&utm_content =25-04-2024 Portable Ultrasound Market: Future Outlook The global Portable Ultrasound Market is segmented by product (Devices [by Portability {Point-of-care (PoC) Ultrasound (Machines and Transducers), Handheld Ultrasound}, by Technology {2D, 3D & 4D, Doppler}, by Display {Black & White (B/W), Colored}], Gels, Accessories), Application ( OB/GYN, Cardiovascular, Urology, Musculoskeletal, Breast Cancer, Other Applications), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Care Centers, Other End Users) and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels. Based on product, the global portable ultrasound market is segmented into devices, gels, and accessories. In 2024, the devices segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing demand for POCUS in emergency departments, increasing preference for ultrasound imaging near patients, the growing prevalence of chronic diseases, and technological advancements in portable ultrasound devices. Based on portability, the devices segment is further sub-segmented into point-ofcare (PoC) ultrasound and handheld ultrasound. The handheld ultrasound segment is expected to register a higher CAGR during the forecast period. This growth is attributed to the development and introduction of new handheld ultrasound devices tailored for specific applications, integration of artificial intelligence (AI) and machine learning, and other technological advancements. Based on application, the global portable ultrasound market is segmented into OB/GYN, cardiovascular, urology, musculoskeletal, breast cancer, and other applications. In 2024, the OB/GYN segment is expected to account for the largest share of the global portable ultrasound market. The large market share of this segment can be attributed to the growing prevalence of conditions related to women’s reproductive health, reduction in global infertility rates, and high incidence & rising awareness regarding early diagnosis and monitoring of PCOD & PCOS. Request Sample: https://www.meticulousresearch.com/request-samplereport/cp_id=5800?utm_source=PR&utm_medium=social&utm_campaign=product &utm_content=25-04-2024 According to data published by the WHO in 2023, Polycystic ovarian syndrome (PCOS) is characterized by an ovary with a follicle count ≥12 and a size of 2 or 3 mm3. This syndrome produces side effects related to women’s overall health, such as abnormal hair growth, weight gain, irregular menstrual cycle, infertility, and depression. Almost 70% of women with PCOS have infertility, and this condition is one of the common reasons for female infertility. PCOS occurs in women during their reproductive years, between 18 and 45 years old. Based on end user, the global portable ultrasound market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory care centers, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the portable ultrasound market. The large market share of this segment is attributed to the increasing hospitalizations due to chronic diseases associated with an aging population, increasing healthcare expenditure, the adoption of advanced imaging modalities in hospitals, preference for low-cost products to control healthcare costs, rising focus on providing point-of-care/bedside service to patients, and the proliferation of healthcare facilities especially in emerging economies. Portable ultrasound systems, including POCUS and handheld ultrasound, can be used near patient areas and do not require patients to visit special medical imaging centers for the diagnosis of various medical conditions. Moreover, getting a bedside medical imaging facility helps healthcare professionals in early diagnosis and treatment planning, driving the adoption of portable ultrasound in hospitals and clinics. Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. China is expected to register the highest CAGR during the forecast period (2024-2031). This growth can be attributed to the rising incidence of orthopedic injuries and cancer, the aging demographic, government initiatives aimed at encouraging early disease detection, the widespread adoption of advanced medical technologies, ongoing improvements in healthcare infrastructure, and increasing healthcare spending. Buy Now: https://www.meticulousresearch.com/Checkout/41100108?utm_source=PR&utm_ medium=social&utm_campaign=product&utm_content=25-04-2024 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulousresearch  ^update (Added: Fri Apr 26 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• Pet Food Ingredients Market - Global Opportunity Analysis and Industry Forecast (2024-2031) - Meticulous Research®—leading global market research company, published a research report titled ‘Pet Food Ingredients Market by Type (Meat & Poultry, Fish, Maize, Wheat, Additives, Novel Ingredients), Application (Pet Meals {Dry Meal}, Pet Treats, Pet Snacks, Veterinary Diet), Pet Type (Dog, Cat, Birds, Ornamental Fish) - Global Forecast to 2031’. Get Free Sample Report: https://www.meticulousresearch.com/download-samplereport/cp_id=5734?utm_source=PR&utm_medium=social&utm_campaign=product&utm_ content=26-04-2024 According to this latest publication from Meticulous Research®, the pet food ingredients market is projected to reach $73.30 billion by 2031, at a CAGR of 8.5% from 2024 to 2031.The growth of the pet food ingredients market is driven by the rising pet population coupled with increasing expenditure on pet food, the growing demand for premium pet food, and an increasing focus on pet health and wellness. However, the stringent regulatory structures and fluctuating raw material prices restrain the growth of this market. Furthermore, the increasing availability and growing acceptance of novel pet food ingredients and the proliferation of direct-to-consumer (D2C) brands and start-ups in the pet food category are expected to provide growth opportunities for the stakeholders operating in this market. However, the risk of counterfeit products is a major challenge impacting the growth of the pet food ingredients market. Moreover, the rising demand for customized pet food is a major trend in the pet food ingredients market. Key Players The pet food ingredients market is moderately competitive due to the presence of many large and small-sized global, regional, and local players. The key players operating in the pet food ingredients market are Cargill, Incorporated (U.S.), Ingredion Incorporated (U.S.), Darling Ingredients Inc. (U.S.), Kemin Industries, Inc. (U.S.), Archer-Daniels-Midland Company (U.S.), Omega Protein Corporation (U.S.), Roquette Frères (France), BASF SE (Germany), Protix B.V. (Netherlands), Duynie Ingredients (Netherlands), Chr. Hansen Holding A/S (Denmark), DSMFirmenich AG (Switzerland), Symrise AG (Germany), IQI b.v. (Netherlands), and KAGOME Australia Pty Ltd (Australia). Browse in Depth: https://www.meticulousresearch.com/product/pet-food-ingredientsmarket- 5734?utm_source=PR&utm_medium=social&utm_campaign=product&utm_content=26-04-2024 The pet food ingredients market is segmented by type (animal-based ingredients {meat &poultry and fish}, plant-based ingredients {cereals & grains[corn/maize, wheat, rice, and other cereals & grains], oilseeds & pulses, fruits & vegetables [carrot residue and other fruits & vegetables], and other plant-based ingredients}, additives, and novel ingredients), application (pet meals {dry meals and wet meals}, treats & snacks, veterinary diets, and other applications), pet type (dogs, cats, birds, ornamental fish, and other pet animals), and geography (North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa). The study also evaluates industry competitors and analyzes the market at the regional and country levels. Based on type, the global pet food ingredients market is segmented into animal-based ingredients, plant-based ingredients, additives, and novel ingredients. In 2024, the animalbased ingredients segment is expected to account for the largest share of the global pet food ingredients, mainly due to the widespread adoption of animal by-products in pet food manufacturing, considering their high protein content, balanced amino acid profiles, better digestibility, and palatability. Request Sample: https://www.meticulousresearch.com/request-samplereport/cp_id=5734?utm_source=PR&utm_medium=social&utm_campaign=product&utm_ content=26--04-2024 Based on application, the global pet food ingredients market is segmented into pet meals, treats & snacks, veterinary diets, and other applications. In 2024, the pet meals segment is expected to account for the largest share of the global pet food ingredients market, owing to the increasing demand for convenient and nutritionally balanced pet meals catering to the specific dietary needs of pets. Moreover, the cost-effectiveness, ease of storage, and high energy content of pet meals, the increased spending on premium meals, and the growing demand for customized meals also contribute to the segment’s large market share. Further, the pet meals application is segmented into dry meals and wet meals. Based on pet type, the global pet food ingredients market is segmented into dogs, cats, birds, ornamental fish, and other pet animals. In 2024, the dog’s segment is expected to account for the largest share of the global pet food ingredients market, mainly due to the increased number of dog adoptions, the growing demand for high-quality dog food products, and increasing awareness about the nutritional benefits of dog foods. Moreover, continuous innovation in pet food production and increasing investments in dog food ingredients are supporting the growth of this segment. Geographic Review This research report analyzes major geographies and provides comprehensive analyses for North America (U.S. and Canada), Europe (Germany, France, U.K., Spain, Poland, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the pet food ingredients market due to the rising number of millennials as pet owners in the region, the growing focus on the health and diets of pets, and the presence of major pet food manufacturers in the region. Quick Buy: https://www.meticulousresearch.com/Checkout/83367472?utm_source=PR&utm_mediu m=social&utm_campaign=product&utm_content=26-04-2024 About Meticulous Research® Meticulous Research® is a leading global market research company committed to providing meticulously crafted research reports and consulting services to clients worldwide. With a dedicated team of industry experts and analysts, we strive to deliver actionable insights and strategic recommendations to empower businesses in making informed decisions. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulousresearch  ^update (Added: Fri Apr 26 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Genome Revolution: Top 10 Companies in the Genomics Market - The global Genomics Market is poised for significant expansion, with forecasts indicating a value surpassing $70.52 billion by 2031, showcasing a resilient Compound Annual Growth Rate (CAGR) of 11.1% from 2024 to 2031. Genomics, the study of genomes encompassing structure, function, evolution, and mapping, plays a pivotal role across various sectors, including medicine, agriculture, biotechnology, and ecology. By unraveling the genetic blueprint of organisms, genomics enables targeted therapies, agricultural innovations, and insights into evolutionary dynamics and ecological relationships. Market Dynamics Driving Growth: The growth of the genomics market is propelled by several factors, including the rising prevalence of genetic diseases, integration of genomic data in clinical practices, increased funding for genomics projects, expanding applications in healthcare, and heightened pharmaceutical research and development investments. However, challenges such as the absence of standardized approaches and concerns regarding data security and privacy hinder market expansion. Furthermore, the adoption of personalized medicines and gene therapies presents new growth avenues, albeit accompanied by challenges such as the scarcity of skilled bioinformatics professionals and the commercialization and scalability of genomic technologies. Top 10 Companies Shaping the Genomics Landscape: https://meticulousblog.org/top-10-companies-in-genomics-market/ Here are the leading companies driving innovation and progress in the Genomics Market: 1. Thermo Fisher Scientific Inc. (U.S.): With a rich history dating back to 2006, Thermo Fisher Scientific leads the pack in biotechnology. Headquartered in Massachusetts, U.S., their comprehensive suite of genomics products spans the globe, supporting life sciences research and patient diagnostics. 2. Illumina, Inc. (U.S.): Since its inception in 1998, Illumina has been synonymous with groundbreaking sequencing and array-based solutions. Based in California, U.S., their products are pivotal in genetic and genomic analysis across various sectors, from research institutions to commercial laboratories. 3. Qiagen N.V. (Netherlands): Venlo, Netherlands, is home to Qiagen, a trailblazer in sample and assay technologies. Their offerings in molecular diagnostics and applied testing are indispensable in both academic and pharmaceutical research worldwide. 4. Danaher Corporation (U.S.): Founded in 1969, Danaher Corporation has evolved into a global science and technology juggernaut. Operating in over 60 countries, their genomics products underpin advancements in life sciences, diagnostics, and environmental sectors. 5. Agilent Technologies, Inc. (U.S.): California-based Agilent Technologies specializes in application-focused solutions for life sciences and diagnostics. Their genomic products, ranging from mutation detection to gene expression profiling, are instrumental in unraveling genetic mysteries. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=1262 6. Bio-Rad Laboratories, Inc. (U.S.): Since 1952, Bio-Rad Laboratories has been a stalwart in developing products for life science research and clinical diagnostics. With facilities across the western U.S. and Europe, their genomics offerings are driving innovation in biological analysis. 7. Pacific Biosciences of California, Inc. (U.S.): California's Pacific Biosciences is synonymous with advancing sequencing solutions. Their technology aids researchers worldwide in solving genetically complex problems across diverse sectors. 8. Oxford Nanopore Technologies Plc. (U.K.): Founded in 2005, Oxford Nanopore Technologies pioneers real-time DNA/RNA sequencing. Operating in over 120 countries, their nanopore-based platform is revolutionizing genomic analysis. 9. Reevity, Inc. (Formerly PerkinElmer, Inc.) (U.S.)- Formerly known as PerkinElmer, Revvity Inc. is a multinational powerhouse offering solutions across the life sciences and diagnostics spectrum. Their genomics products, distributed in over 190 countries, are driving advancements in research and diagnostics. 10. BGI Genomics Co.,Ltd. (China): Shenzhen-based BGI Genomics is a global provider of precision medicine solutions. With an extensive network spanning over 100 countries, their integrated genomic sequencing and proteomic services are at the forefront of medical research. About Us: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Fri Apr 26 2024 Hits: 70 Rating: 0.00 Votes: 0) Rate It

• Compact Ultrasound Solutions: The Top 10 Companies Powering Mobility - The global Portable Ultrasound Market is poised for significant growth, with projections indicating a Compound Annual Growth Rate (CAGR) of 7.9% from 2024 to 2031, ultimately reaching a valuation of $3.8 billion by 2031. This optimistic forecast, outlined by leading research firm Meticulous Research, underscores the market's robust trajectory fueled by various key factors. Market Dynamics: The Portable Ultrasound Market encompasses consumables, instruments, and software & services, catering to a wide array of healthcare needs. Key drivers propelling market growth include: - Rise in Geriatric Population: The increasing elderly population worldwide is driving the prevalence of chronic diseases, thus boosting the demand for portable ultrasound devices. - Growing Adoption in Emergency Care: Portable medical devices, including ultrasound systems, are witnessing heightened adoption in emergency care settings, contributing to market expansion. - Proliferation of Hospitals: The establishment of hospitals, particularly in emerging economies, is creating avenues for the deployment of portable ultrasound technologies. - Demand in Ambulatory Care Centers: Handheld ultrasound devices are increasingly sought after in ambulatory care centers and dialysis centers, further augmenting market growth. Opportunities and Challenges: The preference for portable ultrasound devices over standard machines among healthcare professionals presents lucrative growth opportunities. Additionally, the rising demand from emerging economies is poised to fuel market expansion. However, challenges such as regulatory hurdles and technological limitations may hinder market growth to some extent. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-portable-ultrasound-market/ Top 10 Companies Leading the Portable Ultrasound Market: 1. GE Healthcare Technologies Inc. (U.S.): Offering a broad portfolio of medical technology and digital solutions, GE Healthcare Technologies specializes in ultrasound systems tailored for various clinical areas. 2. Koninklijke Philips N.V. (Netherlands): Koninklijke Philips N.V. develops precision diagnosis solutions, including portable ultrasound devices, through its Diagnosis & Treatment business segment. 3. Siemens Healthineers AG (Germany): Siemens Healthineers provides a wide range of healthcare products and solutions, including portable ultrasound systems, under its Imaging business segment. 4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China): Mindray offers ultrasound diagnostic systems catering to hospitals, clinics, and imaging centers globally, with a focus on clinical specialties. 5. Butterfly Network, Inc. (U.S.): Known for its innovative ultrasound-on-chip technology, Butterfly Network develops handheld ultrasound solutions for widespread accessibility in healthcare institutions. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5800 6. Konica Minolta, Inc. (Japan): Konica Minolta offers portable ultrasound machines for various applications, enhancing diagnostic capabilities in healthcare settings. 7. Samsung Medison Co. Ltd. (South Korea): Samsung Medison manufactures diagnostic ultrasound systems across medical fields, focusing on cardiovascular, general imaging, and obstetrics. 8. FUJIFILM Sonosite, Inc. (U.S.): Specializing in point-of-care ultrasound machines, FUJIFILM Sonosite provides portable ultrasound solutions for immediate patient care. 9. ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea): ALPINION MEDICAL SYSTEMS manufactures ultrasound devices, including diagnostic and therapeutic ultrasound systems, catering to diverse healthcare needs. 10. EchoNous, Inc. (U.S.): EchoNous develops AI-driven point-of-care ultrasound devices, facilitating accurate diagnosis and monitoring of common health issues at the point of care. Market Insights from Meticulous Research: According to Meticulous Research's latest publication on the Portable Ultrasound Market, a robust growth rate of 7.9% is anticipated during the forecast period from 2024 to 2031.For comprehensive insights into market trends, key players, and strategic recommendations, refer to Meticulous Research's authoritative report on the Portable Ultrasound Market - Global Opportunity Analysis and Industry Forecast (2024-2031). ContactUs: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research About Us: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets.  ^update (Added: Fri Apr 26 2024 Hits: 90 Rating: 0.00 Votes: 0) Rate It

• Quantum Computing Market Size to Hold USD 1.63 billion by 2035 - A new report on the Global quantum computing market has been published by the Roots Analysis. Based on the findings of the report, The global quantum computing market size is estimated to grow from USD 0.36 billion in 2023 to USD 1.63 billion by 2035, representing a CAGR of 13% during the forecast period 2023-2035. The rising technological advancements in the quantum computing Market and the increasing investments in the research and development activities are augmenting the market growth. According to the market experts and the observations from our research analysts it is expected that the advancements in the technology and the supportive initiatives from the government will help the quantum computing Market grow in the coming years. Competitive Landscape: Accenture, Aurora Fine Chemicals, Amazon Web Services, Huawei, IBM, Microsoft, Fujitsu, Xanadu and XtalPi. The information that is profiled for each of the market player will include their primary foundation business model as well as their current business strategy, SWOT analysis, their market share, revenue, gross margin, pricing, and the recent developments. The Questions that are Answered in the Report: • What are the top opportunities and trends that are currently ruling the market? • What are the drivers that are shaping the quantum computing Market? • What are the opportunities and challenges for the quantum computing Market created by the outbreak of the COVID-19? • What are the segments of the market for quantum computing that are included in the report? • What are the regional developments prominent in the quantum computing Industry? The other important aspect that has been covered in the quantum computing Market report is the COVID-19 impact on the market. The lockdown in several regions and the economic crunch faced by the regions have severely influenced the market for quantum computing. Several projects and new product launches were disrupted owing to the outbreak of the pandemic. All these detailed analyses have been mentioned in the report. Outbreak of the pandemic has led to several market issues around the world. It has led to economic crisis in various regions along with loss of employment. The quantum computing Market dossier will provide you an assessment of the existing market opportunities in various regions and will also evaluate the market shares in terms of revenue and volume. The key quantum computing Industry segments that are covered in the report are (Product, Application, End-use and others). The regions that are covered include Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. The quantum computing Market report will offer you detailed information about the evaluations that came across during the research study that has helped the market structure in the historical period and the aspects that will shape the market during the forecast period 2023-2035. Quantum computing Market Report Insights: • Global quantum computing Market segmentation in terms of Product, Application, End-use, and regions and others. • Overview of the quantum computing Market, its scope, and target audience. • In-depth description about the market drivers, restraints, future market opportunities, and challenges. • Details about the advanced technologies, including big data & analytics, artificial intelligence, and social media platforms used by the global quantum computing Market. • Primary legislations that will have a great impact on the global platform. • Comprehensive analysis about the key players in the global market for quantum computing. • Recent developments, mergers and acquisitions, collaborations, R&D projects are mentioned in the quantum computing Industry report. What to Expect in Our Report? • Executive Summary: A brief overview of the quantum computing Industry report's key findings, highlighting the most important points and insights. • Introduction: An introduction to the quantum computing Market Overview: A comprehensive analysis of the global quantum computing Market, including market size, historical data, and projected growth rates. • Market Dynamics: An examination of the key drivers, challenges, and opportunities shaping the market for quantum computing. This section may include factors such as consumer trends, regulatory landscape, technological advancements, and industry developments. • Market Segmentation: A detailed breakdown of the market by product type, application, end-use sector, and geographic region. This section provides insights into the market share and growth prospects of each segment. • Competitive Landscape: An assessment of the competitive scenario in the market, including profiles of major companies, their market shares, recent developments, and strategies. • Market Forecast: A forward-looking analysis of the market's future prospects, including projected market size, growth rates, and emerging trends. • Industry Challenges and Opportunities: A discussion of the major challenges faced by industry players and potential opportunities for growth and innovation. • Regulatory Environment: An overview of the regulatory frameworks, standards, and certifications relevant to the production and use of quantum computing. • Emerging Technologies and Innovations: An exploration of the latest technological advancements and innovations in the quantum computing Industry, including sustainable and natural ingredient alternatives. • Consumer Insights: A deeper understanding of consumer preferences, buying behavior, and trends in the quantum computing Market. • Case Studies: Real-world examples and case studies highlighting successful strategies, product launches, and market penetration in the quantum computing Industry. Browse Full Research Report with [TOC] @ https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html  ^update (Added: Thu Apr 25 2024 Hits: 78 Rating: 0.00 Votes: 0) Rate It

• Prime Healthcare | Saving Hospitals, Saving Jobs, Saving Lives. - Prime Healthcare is the fifth largest for-profit health system in the United States operating 44 hospitals in 14 states, more than 300 outpatient locations, and nearly 45,000 employees and affiliated physicians dedicated to providing the highest quality, value-based healthcare. https://www.primehealthcare.com/about-prime/  ^update (Added: Thu Apr 25 2024 Hits: 66 Rating: 0.00 Votes: 0) Rate It

• Prime Healthcare | Saving Hospitals, Saving Jobs, Saving Lives. - Prime Healthcare is the fifth largest for-profit health system in the United States operating 44 hospitals in 14 states, more than 300 outpatient locations, and nearly 45,000 employees and affiliated physicians dedicated to providing the highest quality, value-based healthcare. https://www.primehealthcare.com/about-prime/  ^update (Added: Thu Apr 25 2024 Hits: 64 Rating: 0.00 Votes: 0) Rate It

• The Top 10 Companies Powering Remote Patient Monitoring - The Remote Patient Monitoring (RPM) Market is on a trajectory of significant expansion, with a projected valuation of $116.84 billion by 2031, boasting a robust Compound Annual Growth Rate (CAGR) of 13.7% from 2024. This forecast, presented by Meticulous Research®, underscores the market's promising prospects, driven by several key factors. 🚀 Key Drivers Fueling Market Expansion The market's growth is primarily fueled by the escalating global geriatric population, the surge in chronic diseases prevalence, and the pressing global shortage of healthcare professionals. Moreover, growing awareness regarding the myriad benefits of RPM, including enhanced patient outcomes and convenience, alongside the imperative to curtail healthcare costs, are further propelling market expansion. Additionally, favorable government initiatives advocating remote patient monitoring are augmenting market growth. The landscape is ripe with opportunities, spurred by technological advancements in telehealth and remote patient monitoring, the emergence of economies with burgeoning patient populations, and the increasing adoption of wearable devices. Furthermore, advancements in sensor technologies and the integration of artificial intelligence with RPM solutions present promising avenues for market advancement. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-remote-patient-monitoring-market/ Top 10 Companies Leading the Remote Patient Monitoring Market 1. Medtronic plc (Ireland): Established in 1949, Medtronic is a global healthcare technology company pioneering biomedical engineering products aimed at alleviating pain, restoring health, and extending life. With a presence in over 150 countries, Medtronic's Cardiovascular and Medical Surgical Portfolios spearhead its engagement in the remote patient monitoring market. 2. Koninklijke Philips N.V. (Netherlands): Founded in 1891, Philips is a health technology company driving innovation in healthcare and electronics sectors. Its Connected Care segment, operating in remote patient monitoring, offers innovative solutions across Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care, and Connected Care Informatics. 3. OMRON Corporation (Japan): Since 1933, OMRON has been a stalwart in automation and healthcare, offering cutting-edge sensing and control products. Its Healthcare Business segment, operating in the remote patient monitoring market, spans a wide geographic presence of around 120 countries/regions worldwide. 4. Boston Scientific Corporation (U.S.): Established in 1979, Boston Scientific specializes in developing minimally invasive medical technologies, offering alternatives to surgery. The company's Cardiovascular segment, engaged in remote patient monitoring, is dedicated to improving patient health globally. 5. Siemens Healthineers AG (Germany): Founded in 1847, Siemens Healthineers is a global provider of healthcare solutions, offering diagnostic and therapeutic products. With a presence in more than 70 countries, Siemens Healthineers operates in the remote patient monitoring market through its extensive portfolio of innovative solutions. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5343 6. Abbott Laboratories (U.S.): Since 1888, Abbott Laboratories has been a stalwart in the healthcare industry, offering a diverse portfolio of products ranging from diagnostics to medical devices. The company's Medical Devices segment, operating in remote patient monitoring, is committed to advancing patient care globally. 7. GE Healthcare Technologies, Inc. (U.S.): With roots dating back to 1892, GE Healthcare Technologies specializes in enhancing health system capacity and improving clinical outcomes. The company's Patient Care Solutions segment, engaged in remote patient monitoring, is pivotal in driving healthcare innovation worldwide. 8. F. Hoffmann-La Roche AG (Switzerland): Established in 1896, Roche is a leading pharmaceutical and diagnostics company with a global presence. Operating in the remote patient monitoring market through its Diagnostics segment, Roche is dedicated to delivering innovative solutions for patient care. 9. Baxter International, Inc. (U.S.): Since 1931, Baxter International has been a frontrunner in providing essential healthcare products worldwide. With a focus on Healthcare Systems and Technologies, Baxter's segment operating in remote patient monitoring is dedicated to optimizing patient care globally. 10. DexCom, Inc. (U.S.): Founded in 1999, DexCom specializes in continuous glucose monitoring systems for diabetes patients. With a global presence, DexCom's commitment to enhancing patient care is evident through its innovative solutions in remote patient monitoring. 📊 Market Projections and In-Depth Analysis : Meticulous Research®'s latest report on the Remote Patient Monitoring Market anticipates a robust CAGR of 13.7% during the forecast period from 2024 to 2031. For comprehensive insights into market trends, key players, and strategic recommendations, refer to Meticulous Research®'s authoritative report on the Remote Patient Monitoring Market – Global Opportunity Analysis and Industry Forecast (2024-2031). Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research About Us: We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets.  ^update (Added: Thu Apr 25 2024 Hits: 63 Rating: 0.00 Votes: 0) Rate It

• How ProDentim is Revolutionizing Oral Health Practices in 2024 - With everything taken into account, Prodentim's method for managing confirmation based dentistry reflects a guarantee to significance in tireless thought. By organizing the latest investigation, clinical fitness, and patient data, they ensure that each piece of their preparation is grounded in sensible evidence and custom fitted to meet the solitary prerequisites of each and every patient. Through a productive method for managing treatment organizing, the use of pattern setting development, and a culture of consistent quality improvement, Prodentim sets a standard of significance in current dentistry. For those searching for a smile as well as a tentatively solid one, Prodentim stays as a source of perspective place of verification based dental thought. There is no question about the way that brushing is the way in to a sound grin. Day or night, it is a definitive schedule that everybody follows for solid teeth and gums. However, the squeezing question here is, would you say you are involving the right weapon to get everything done? In all honesty, your dependable toothbrush assumes a significant part in keeping your silvery whites sans plaque and your gums blissful. In any case, with racks spilling over with electric wonders and manual wonders, picking the right brush can feel overpowering. Dread not, individual brush wielders! ProDentim, your oral consideration probiotic accomplice, is here to reveal insight into the universe of toothbrushes and assist you with tracking down your ideal pair. Indeed, we'll let you know who to swipe right on. (for your dental consideration, clearly!) The Electric versus Manual Standoff: Pick Your Boss! Priorities straight, electric or manual? Both have their assets: Oscillating brushes: These hotshot brushes can eliminate up to 100 percent more plaque [Source: American Dental Association] than manual brushes, making them ideal for the people who need a more profound clean or battle with finesse. Numerous rotating brushes additionally accompany helpful elements like clocks and strain sensors to direct you toward a dental specialist commendable spotless.  ^update (Added: Thu Apr 25 2024 Hits: 281 Rating: 0.00 Votes: 0) Rate It

• Top 10 Companies in the Parenteral Nutrition Bags Market - The Clinical Lab Automation Market is poised for significant expansion, projected to achieve a valuation of $3.72 billion by 2030, with a robust Compound Annual Growth Rate (CAGR) of 7.8% from 2023. This forecast, presented by [Your Company Name], underscores the market's escalating trajectory, driven by several key factors. Market Dynamics: The market's growth is primarily attributed to the escalating global geriatric population, a surge in the prevalence of infectious diseases, and notable advancements in clinical laboratory instruments technology. However, challenges such as the high costs associated with advanced clinical lab automation equipment, as well as funding and infrastructure limitations in developing nations, present hurdles to market expansion. Challenges And Opportunities: Despite these challenges, emerging opportunities abound, fueled by the growing demand for automated instruments, advancements in molecular diagnostics technology, and the burgeoning economies poised for substantial growth. Nevertheless, concerns over high equipment maintenance and repair costs, alongside apprehensions regarding the security and privacy of patient data, continue to pose challenges for sustained market growth. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-clinical-lab-automation-market/ Top 10 Companies Leading the Clinical Lab Automation Market 1. Danaher Corporation (U.S.): Danaher, established in 1969, operates across various sectors, including Biotechnology, Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company's Diagnostics segment offers a comprehensive array of clinical instruments, reagents, consumables, software, and services, catering to critical care settings. 2. Hamilton Company (U.S.): Founded in 1953, Hamilton specializes in precision measurement devices, automated liquid handling workstations, and sample management systems, offering solutions in the clinical lab automation market through its Automation category. 3. Abbott Laboratories (U.S.): With roots dating back to 1888, Abbott Laboratories is renowned for its extensive range of healthcare products, including diagnostics, medical devices, nutrition, and branded generic pharmaceuticals, operating globally through four business segments. 4. F. Hoffmann-La Roche AG (Switzerland): Established in 1896, Roche is a distinguished player in pharmaceuticals and diagnostics, offering differentiated medicines and a wide range of in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. 5. Thermo Fisher Scientific Inc. (U.S.): Founded in 1956, Thermo Fisher Scientific provides a comprehensive suite of products and services catering to various sectors, including pharmaceutical, biotechnology, clinical, healthcare, government, and academic institutions. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5762 6. Siemens Healthineers AG (Germany): Siemens Healthineers, operating since 1847, is a leading provider of healthcare solutions and services, specializing in PCR systems, immunoassays, and solutions for efficient workflow within the diagnostics segment. 7. Agilent Technologies, Inc. (U.S.): Established in 1999, Agilent Technologies offers application-focused solutions, including liquid chromatography, gas chromatography, mass spectrometry, spectroscopy, lab automation, robotics, and related agents, targeting laboratory workflow efficiency. 8. Tecan Group Ltd. (Switzerland): Founded in 1980, Tecan Group specializes in automated laboratory instruments and solutions for applications in biopharmaceuticals, forensics, and clinical diagnostics, with a wide global distribution network. 9. Becton, Dickinson, and Company (U.S.): Established in 1897, BD is a medical technology company manufacturing and selling a wide range of medical devices, laboratory equipment, and diagnostic products, with a global presence across various segments. 10. Waters Corporation (U.S.): Founded in 1958, Waters Corporation is a specialty measurement company offering high-performance liquid chromatography, ultra-performance liquid chromatography, and mass spectrometry technology systems and support products. 📊 Market Projections and In-Depth Analysis : Meticulous Research®'s latest report on the Clinical Lab Automation Market anticipates a robust CAGR of 7.8% during the forecast period from 2023 to 2030. For comprehensive insights into market trends, key players, and strategic recommendations, refer to Meticulous Research®'s authoritative report on the Clinical Lab Automation Market – Global Opportunity Analysis and Industry Forecast (2023-2030). Contact Information: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Thu Apr 25 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• Defibrillator Market to be Worth $22.76 Billion by 2031 - Meticulous Research®—a leading market research company, published a research report titled, 'Defibrillator Market by Product (Implantable (ICD) [Transvenous {Dual Chamber, Single-chamber, CRT-D}, Subcutaneous], External (ECD) [Manual, Automated, Wearable]), End User (Hospital, Emergency Care, Home Care), Age Group – Global Forecast to 2031.’ According to this latest publication from Meticulous Research®, the defibrillator market is projected to reach $22.76 billion by 2031, at a CAGR of 6.9% from 2024 to 2031. The growth of the defibrillator market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity incidence, the adoption of a sedentary lifestyle, and excessive consumption of alcohol & caffeinated products, technological advancements in defibrillator devices and the rising geriatric population. However, the lack of skilled professionals and the increase in reported cases of defibrillator malfunctions & product recalls restrains market growth. The high incidence of clinical adverse events attributed especially to high-risk medical devices has led to an advocated change from many stakeholders. This is especially true with respect to devices like cardiac implants, with their high-risk nature and high complication rates associated with considerable mortality due to their frequent use in older populations with frequent co-morbidities. For instance, in July 2023, Medtronic plc (Ireland) recalled their Implantable Cardioverter Defibrillators (ICDs) Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) with glassed feedthrough for risk of low or no energy output during high voltage therapy. The reason for this recall was the failure of the devices to deliver low or no energy output, which can fail to correct arrhythmias, leading to cardiac arrest, other serious injuries, or death. Key Players The key players profiled in the defibrillator market report are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se & Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL Medical Corporation (U.S.). The defibrillator market is segmented by Product (Implantable Cardioverter Defibrillators [Transvenous Implantable Cardioverter Defibrillators {Cardiac Resynchronization Therapy Defibrillators (CRT-D), Dual-Chamber Implantable Cardioverter Defibrillators, Single-chamber Implantable Cardioverter Defibrillators}, Subcutaneous Implantable Cardioverter Defibrillators], External Cardiac Defibrillators [Manual ECD, Automated ECD {Semi-automated ECD, Fully-automated ECD}, Wearable ECD), Age Group (Adult, Children), End User (Hospital and Ambulatory Surgery Centers, Pre Hospital/Emergency Care, Public Access Programs, Alternative/Foster Care, and Homecare), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets. Among products, in 2024, the implantable cardioverter defibrillators segment is expected to account for the largest share of the market. The large share of the segment is attributed to the rising adoption of permanent implantable cardioverter defibrillators for the prevention of sudden cardiac arrest and related deaths in patients at high risk of it. Technological developments leading to the development of advanced defibrillators are supporting the largest market share. For instance, in March 2022, Rapid Response Revival Research Ltd (U.K.) launched CellAED, which is a personal defibrillator, which is a handheld device that improves the chances of surviving a sudden cardiac arrest. This device is portable and easy to use and does not require any special medical training. Among age groups, in 2024, the adult segment is expected to account for the larger share of the market. Defibrillators are used to regulate irregular heartbeats or revive the heart in case of a sudden cardiac arrest. Increasing incidence of obesity, sedentary workstyle, and excessive consumption of alcohol and caffeinated products increases the risk of cardiac arrests, particularly in the adult population, as these risk factors are more prevalent in adults than children. For instance, as per data updated by the Sudden Cardiac Arrest Foundation (U.S.), in the U.S., the annual incidence of out-of-hospital cardiac arrests (OHCA) reported is 347,322 in adults, compared to 7,037 in children. Thus, the demand for defibrillators is higher in adults compared to children. Among end users, in 2024, the hospitals segment is expected to account for the largest share of the market. Being one of the most conventional and highly preferred healthcare settings with wide presence, easy accessibility, and better healthcare infrastructure, most of the patients initially visit hospitals for any healthcare concerns. The large share of the market is attributed to factors such as the large pool of patients with cardiovascular diseases visiting the hospitals for diagnosis & treatment of cardiac diseases, easy accessibility, and better healthcare facilities in hospitals as compared to other healthcare institutions. Among geographies, in 2024, North America is expected to account for the largest share of the market. The U.S. is the largest share-holding country in North America. The large share of this region is attributed to factors such as increasing incidence of cardiovascular diseases among the rising geriatric population, increasing burden of hypertension; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in this region. For instance, according to the Centers for Medicare & Medicaid Services (CMS), the U.S. healthcare expenditure was $4.5 trillion in 2022 as compared to $4.3 trillion in 2021. Along with this, the increasing number of chronic diseases, the presence of large medical device manufacturers in this region, and increased accessibility & higher adoption of technically advanced medical devices are driving the growth of defibrillator devices in the country. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3596 Key questions answered in the report: • Which are the high-growth market segments in terms of defibrillators by product, age group, end user, and geography? • What was the historical market for defibrillators across the globe? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, opportunities, and challenges in the defibrillator market? • Who are the major players operating in the defibrillator market? • What is the competitive landscape like, and who are the leaders in the defibrillator market? • What are the recent developments in the defibrillator market? • What are the different strategies adopted by the major players in the defibrillator market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Thu Apr 25 2024 Hits: 77 Rating: 0.00 Votes: 0) Rate It

• The Top 10 Companies Powering Parenteral Nutrition - The Parenteral Nutrition Bags Market to soar to $1.25 billion by 2031, growing at an impressive CAGR of 6.6% from 2024 to 2031. This projection comes amid a backdrop of increasing chronic and infectious diseases, a rising prevalence of malnutrition globally, a surge in premature births, and a growing incidence of metabolic disorders. Additionally, the market is fueled by the expanding adoption of home healthcare, the burgeoning global geriatric population, and the emergence of economies with significant growth potential. However, concerns surrounding infection risks linked to parenteral nutrition remain a key restraint hindering market expansion. Furthermore, a lack of awareness regarding parenteral nutrition in developing nations poses a significant challenge to market growth. 🌐 Top 10 Companies Leading the Charge: https://meticulousblog.org/top-10-companies-in-parenteral-nutrition-bags-market/ Top 10 Companies Driving the Parenteral Nutrition Bags Market: 1. B. Braun SE (Germany): Established in 1839, B. Braun SE offers a comprehensive range of medical technology-based products, including parenteral nutrition bags, through its Hospital Care division. 2. Baxter International, Inc. (U.S.): Baxter International, Inc., founded in 1931, provides essential healthcare products, including parenteral nutrition bags, as part of its infusion therapies and technologies segment. 3. Fresenius Kabi AG (Germany): Formed in 1999, Fresenius Kabi AG specializes in infusion therapy and clinical nutrition products, offering parenteral nutrition bags among its extensive product portfolio. 4. GVS S.p.A. (Italy): Founded in 1979, GVS S.p.A. manufactures filter solutions, including parenteral nutrition bags, for applications in healthcare and life sciences. 5. Grifols, S.A. (Spain): With a history dating back to 1909, Grifols, S.A. develops plasma-derived medicines and offers parenteral nutrition bags as part of its hospital management solutions. 6.Technolflex (France): Established in 1972, Technolflex designs and produces medical devices, including parenteral nutrition bags, catering to various healthcare applications. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5792 7. RENOLIT SE (Germany): Founded in 1946, RENOLIT SE manufactures plastic products, including parenteral nutrition bags, for medical and pharmaceutical applications. 8. Valmed s.r.l. (Italy): Established in 2007, Valmed s.r.l. designs, develops, and manufactures medical devices, including parenteral nutrition bags, leveraging advanced technologies. 9. HEMEDIS GmbH (Germany): Founded in 2011, HEMEDIS GmbH specializes in medical equipment for parenteral nutrition preparation and administration, offering a range of parenteral nutrition bags. 10. INFRA Srl (Italy): Established in 1985, INFRA Srl manufactures protective devices and medical components, including parenteral nutrition bags, adhering to stringent quality standards. 📊 Market Projections and In-Depth Analysis : Meticulous Research®'s latest report on the Parenteral Nutrition Bags Market underscores a projected CAGR of 6.6% from 2024 to 2031. The comprehensive analysis delves into the financial performance, product portfolios, strategic initiatives, and market positioning of each key player. About Meticulous Research® We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. Contact Us: Meticulous Research® Email-sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Thu Apr 25 2024 Hits: 75 Rating: 0.00 Votes: 0) Rate It

• DDReg Pharma to Showcase Regulatory and Drug Safety Expertise at BIO International Convention 2024 - [ San Diego] – [03-june 2024] – DDReg Pharma, a leading provider of global regulatory consulting and strategic product development services, today announced its participation at the upcoming BIO International Convention 2024, taking place June 3rd – 6th in San Diego, California. Meeting Growing Needs in Biologics and Cell & Gene Therapies This marks DDReg's first-time exhibiting at BIO International, a premier global event for the biotechnology industry. The company will be showcasing its comprehensive suite of services designed to support the development of biologics, biosimilars, and cell & gene therapy products. “The rapid advancements in the biopharmaceutical space necessitate a strategic partnering approach to ensure compliant and efficient product development,” at DDReg Pharma. “We are excited to connect with fellow exhibitors, attendees, and decision-makers at BIO to demonstrate how our tailored regulatory solutions can help navigate complex regulations and bring life-saving therapies to patients faster.” Inviting Attendees to Connect and Explore Solutions At booth [3751], DDReg representatives will be available to discuss attendees’ specific clinical, regulatory, and drug safety requirements. Attendees can learn more about how DDReg’s global expertise, spanning over 130 countries, can streamline the development process and ensure regulatory compliance throughout the entire product lifecycle. Who Should Attend: Pharmaceutical and biotechnology companies Contract research organizations (CROs) Clinical trial investigators Regulatory professionals Anyone interested in the latest advancements in drug development Join DDReg Pharma at BIO International 2024 The DDReg team invites attendees to visit their booth and explore how their services can help bring innovative therapies to market. Don't miss this opportunity to network with industry leaders, discuss your development challenges, and discover how DDReg can be your trusted partner in achieving regulatory success. About DDReg Pharma DDReg Pharma is a leading global regulatory consulting and strategic product development firm. With extensive experience across diverse therapeutic areas, DDReg provides comprehensive solutions to support the development of safe and effective drugs. The company’s team of scientific and regulatory experts helps clients navigate complex regulations and ensure compliance throughout the entire product lifecycle. Media Contact: [AKSHITA SRIVASTAVA] [Assistant Manager (Business Development)] [bd@ddregpharma.com]  ^update (Added: Wed Apr 24 2024 Hits: 67 Rating: 0.00 Votes: 0) Rate It

• DDReg Pharma to Showcase Regulatory and Drug Safety Expertise at BIO International Convention 2024 - [ San Diego] – [03-june 2024] – DDReg Pharma, a leading provider of global regulatory consulting and strategic product development services, today announced its participation at the upcoming BIO International Convention 2024, taking place June 3rd – 6th in San Diego, California. Meeting Growing Needs in Biologics and Cell & Gene Therapies This marks DDReg's first-time exhibiting at BIO International, a premier global event for the biotechnology industry. The company will be showcasing its comprehensive suite of services designed to support the development of biologics, biosimilars, and cell & gene therapy products. “The rapid advancements in the biopharmaceutical space necessitate a strategic partnering approach to ensure compliant and efficient product development,” at DDReg Pharma. “We are excited to connect with fellow exhibitors, attendees, and decision-makers at BIO to demonstrate how our tailored regulatory solutions can help navigate complex regulations and bring life-saving therapies to patients faster.” Inviting Attendees to Connect and Explore Solutions At booth [3751], DDReg representatives will be available to discuss attendees’ specific clinical, regulatory, and drug safety requirements. Attendees can learn more about how DDReg’s global expertise, spanning over 130 countries, can streamline the development process and ensure regulatory compliance throughout the entire product lifecycle. Who Should Attend: Pharmaceutical and biotechnology companies Contract research organizations (CROs) Clinical trial investigators Regulatory professionals Anyone interested in the latest advancements in drug development Join DDReg Pharma at BIO International 2024 The DDReg team invites attendees to visit their booth and explore how their services can help bring innovative therapies to market. Don't miss this opportunity to network with industry leaders, discuss your development challenges, and discover how DDReg can be your trusted partner in achieving regulatory success. About DDReg Pharma DDReg Pharma is a leading global regulatory consulting and strategic product development firm. With extensive experience across diverse therapeutic areas, DDReg provides comprehensive solutions to support the development of safe and effective drugs. The company’s team of scientific and regulatory experts helps clients navigate complex regulations and ensure compliance throughout the entire product lifecycle. Media Contact: [AKSHITA SRIVASTAVA] [Assistant Manager (Business Development)] [bd@ddregpharma.com]  ^update (Added: Wed Apr 24 2024 Hits: 74 Rating: 0.00 Votes: 0) Rate It

• The Epigenetics Market to be Worth $5.47 Billion by 2030—Exclusive Report by Meticulous Research®” - According to a new market research report titled, ‘Epigenetics Market By Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management) Deployment Mode (Cloud, On-premise) End User (Pharmaceutical, CDMO/CRO)—Global Forecast to 2030,’ published by Meticulous Research®, the epigenetics market is projected to reach $5.47 billion by 2030 at a CAGR of 15.7% from 2023 to 2030. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5628 Epigenetics is phenotypic alteration without permanent genotypic change using several methods, including DNA methylation, histone modification, RNA modification, etc. These modifications play a crucial role in diagnosing and prognosis diseases and disorders. Epigenetics finds its major application in oncology due to the global cancer burden and the growing adoption of precision cancer therapies. The growth of the epigenetics market is driven by the rising incidence of chronic diseases due to growth in the aging population, the increasing prevalence of cancer, rising pharmaceutical R&D expenditures, the increasing focus on epigenetics in drug discovery & development, and the declining costs of genome sequencing. However, the lack of skilled professionals restrains the growth of this market. The growing applications of epigenetics in non-oncology diseases and government initiatives supporting large-scale genomic sequencing projects are expected to generate growth opportunities for the stakeholders in this market. However, standardization concerns associated with epigenetics procedures and the limited applications of epigenetics in toxicology are major challenges to market growth. Growing Prevalence of Cancer is Driving the Demand for Epigenetics Offerings Epigenetics enables pharmaceutical & biotechnology companies to identify and validate disease interactions and mechanisms that can be used in developing new diagnostic tests and therapies. Epigenetic markers are measurable indicators of a biological state or process that can be used to diagnose, monitor, or predict the progression of a disease and identify changes in gene expression, genetic variations, or epigenetic modifications associated with a particular disease or condition. Biotechnology companies utilize epigenetic methods to identify factors influencing cell or gene interactions, reduce the time required to understand factors causing diseases and enable early diagnosis and treatment. Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=5628 The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry over the past years (2020–2022). In the last couple of years, the global Epigenetics Market witnessed several strategic developments. The key players operating in the global Epigenetics Market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), New England Biolabs (U.S.), Epigentek Group Inc. (U.S.), Pacific Biosciences of California Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), 10X Genomics, Inc. (U.S.), Active Motif (U.S.), and Zymo Research Corporation (U.S.). The global epigenetics market study presents historical market data in terms of values (2021 and 2022), estimated current data (2023), and forecasts for 2030. The global epigenetics market is segmented by offering, method, application, and end user. The study also evaluates industry competitors and analyzes their market share at global and regional levels. Based on offering, the epigenetics market is segmented into kits & reagents, software, and services. The kits & reagents segment is expected to grow at the highest CAGR during the forecast period. Kits & reagents are used to study epigenetics through chromatin analysis, histone analysis, DNA methylation, and sequencing, among other methods. Kits are ready-to-use assays that include components such as primers, controls, columns, buffers, beads, inhibitors, and antibodies, depending on the method used for analysis. Reagents are sold separately and can be used in different concentrations depending on the requirements of the procedure/analysis. The recurrent use of kits and reagents and the growing cancer prevalence are the major factors attributed to the segment's fast growth. Based on method, the global epigenetics market is segmented into DNA methylation, histone modification, RNA modification, polymerase chain reaction (PCR), chromatin analysis, sonication, and other methods. In 2023, the DNA methylation segment is expected to account for the largest share of the epigenetics market. DNA methylation is an epigenetic mechanism that involves transferring a methyl group onto the C5 position of cytosine to form 5-methylcytosine. This process regulates gene expression by promoting or inhibiting the binding of transcription factors to DNA. Thus, it is useful in studying epigenetic changes in an organism. The increasing prevalence of cancer, technological advancements in PCR and sequencing, and the high focus on reducing costs associated with lengthy research and product approval processes support the segment’s large share. Quick Buy @ https://www.meticulousresearch.com/Checkout/10022421 Based on application, the global epigenetics market is segmented into oncology and non-oncology. In 2023, the oncology segment is expected to account for the largest share of the market. Epigenetics helps differentiate the nuclear organization, DNA methylation, and histone modification patterns between cancer and normal cells. Several changes in cancer cells, such as lower histone post-translational modifications (methylation or acetylation), are associated with poor outcomes in prostate, lung, and kidney cancers. In contrast, higher levels of a specific histone modification (H3K9ac) are associated with lower survival in lung cancer. Also, a reduction in miR-101 expression has been observed in many cancer types, which leads to increased expression of an enzyme responsible for histone methylation. Such methylation induction in tumor suppressor genes can increase the risk of cancer development. Thus, epigenetic analyses help in the study, early diagnosis, and treatment of cancer, leading to a large segment share. Based on end user, the global epigenetics market is segmented into pharmaceutical and biotechnology companies, academic & research institutes, and hospitals & diagnostic laboratories. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to increasing R&D investments by pharmaceutical & biotechnology companies, the growing prevalence of chronic diseases, and a growing emphasis on personalized medicine. The utilization of epigenetic analysis is growing in precision medicine. Advancements in epigenetic analysis are changing how doctors diagnose and treat cancer. New targeted cancer treatments that use genomic data to provide patient-specific treatments are known as precision oncology. This rapidly developing field has already become a part of mainstream clinical practices. It involves the molecular profiling of cancer cells to identify targetable alterations, also known as biomarkers. Quick and reliable sequencing of multiple genes at once is possible with epigenetic analysis. Epigenetic analysis has helped develop precision medicine, which involves tailoring treatments based on disease-causing molecular/epigenetic changes in a person’s body. In 2023, North America is expected to account for the largest share of the Epigenetics Market. North America’s large market share is primarily attributed to the strong focus of local companies on product launches and enhancements, the presence of key players, the established healthcare system, the growing number of chronic diseases, and the rising geriatric population. Top 10 Companies in Epigenetics Market @ https://meticulousblog.org/top-10-companies-in-epigenetics-market/ About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Wed Apr 24 2024 Hits: 58 Rating: 0.00 Votes: 0) Rate It

• Agricultural Films Industry Set to Hit $23.39 Billion Mark by 2031 - Meticulous Research®, a premier global market research firm, has released its latest report titled 'Agricultural Films Market by Type and Raw Material - Global Forecast to 2031'. The comprehensive study projects the agricultural films market to achieve a valuation of $23.39 billion by 2031, with a notable CAGR of 6.9% during the forecast period spanning from 2024 to 2031. Get Free Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5799?utm_source=press+release+&utm_medium=social&utm_campaign=product&utm_content=24-04-2024 Driving Forces and Growth Catalysts The report identifies several factors fueling the expansion of the Agricultural films market. These include the escalating demand for food driven by population growth, the escalating impact of global warming and climate change, increasing consumer preference for high-quality food produce, and ongoing innovations in agricultural film technologies. However, challenges such as the high installation costs and stringent environmental regulations concerning plastic usage hinder the market's growth potential. Strategic Opportunities and Market Dynamics Amidst these challenges, the emergence of nano greenhouses and the growing adoption of biodegradable films in developed regions present significant growth opportunities for stakeholders. Nevertheless, environmental concerns and plastic waste remain critical challenges to be addressed for sustainable market development. Key Players and Market Segmentation Leading players in the agricultural films market landscape include Berry Global Group, Inc., Coveris Flexibles UK Ltd., RKW SE, BASF SE, and others. The market is segmented by type, raw material, and geography, providing a comprehensive analysis of industry competitors at both regional and country levels. Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=5799?utm_source=press+release+&utm_medium=social&utm_campaign=product&utm_content=24-04-2024 Segment Analysis and Market Trends The report highlights the mulching films segment as the largest market share contributor in 2024, attributed to its diverse benefits such as weed inhibition, moisture preservation, soil temperature regulation, and enhanced crop yields. Meanwhile, the greenhouse films segment is expected to witness substantial growth during the forecast period due to its cost-effectiveness, soil protection properties, and pest control capabilities. Geographic Outlook Geographically, the Asia-Pacific region is poised to dominate the agricultural films market in 2024, driven by increasing adoption of modern farming techniques, rising food demand, supportive government policies, and a focus on high-value crop cultivation. Key Questions Addressed in the Report • Identification of high-growth market segments by type, raw material, and geography. • Historical market size analysis and forecasts for the period 2024–2031. • Examination of major drivers, restraints, opportunities, and challenges shaping market dynamics. • Profiling of key market players and assessment of their market shares. • Evaluation of competitive landscapes, strategies, and key geographic trends. • Analysis of emerging local players and their competitive strategies. Quick Buy @ https://www.meticulousresearch.com/Checkout/10111749?utm_source=press+release+&utm_medium=social&utm_campaign=product&utm_content=24-04-2024 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research  ^update (Added: Wed Apr 24 2024 Hits: 78 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... [>>]